地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：17754422825
传真：18327026838
邮箱：sales@amyjet.com
<艾美捷科技有限公司代理Echelon Biosciences的产品：
http://www.amyjet.com/Index/lists/catid/27/kid/57.html
Echelon Biosciences成立于1997年，致力于为脂质研究领域提供高品质的检测方法和检测试剂。
Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Bioscience的产品和服务包括：
| (2S)-Oleyl LPA (Echelon Bioscience, CAT#L-0186) |
| (E,E,E)-Geranylgeraniol (Echelon Bioscience, CAT#S-0200) |
| (E,E)-Farnesoic acid (Echelon Bioscience, CAT#S-0151) |
| (E,E)-Methyl Farnesoate (Echelon Bioscience, CAT#S-0153) |
| (S,S) Bisoleoyl-lysobisphosphatidic acid (LBPA) (Echelon Bioscience, CAT#L-B181) |
| (S)-FTY720 Phosphate (Echelon Bioscience, CAT#B-0721) |
| [4-(Decanoylamino)benzyl]phosphonic acid (GWJ-23, GWJ-A-23) (Echelon Bioscience, CAT#L-3223) |
| [D-Ala2]-Deltorphin II (Echelon Bioscience, CAT#275-21) |
| [Hyp3]-Bradykinin (Echelon Bioscience, CAT#191-65) |
| [Ser25] Protein Kinase C Substrate (19-31) (Echelon Bioscience, CAT#871-21) |
| 1-Deoxy-D-xylulose (DX) (Echelon Bioscience, CAT#I-M050A) |
| 1-Deoxy-D-xylulose 5-phosphate (DXP) (Echelon Bioscience, CAT#I-M050) |
| 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP) (Echelon Bioscience, CAT#I-M055) |
| 1-Methylhistamine dihydrochloride (Echelon Bioscience, CAT#B-0032) |
| 1-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-76) |
| 1-Stearoyl-2-Arachidonoyl-sn-Glycerol (Echelon Bioscience, CAT#L-0024) |
| 1,2-Distearoyl-sn-glycerol (Echelon Bioscience, CAT#L-0018) |
| 1,3-DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2216) |
| 1,3-POPE (16:0/18:1 PE) (Echelon Bioscience, CAT#L-2368) |
| 16:0 LPE (Echelon Bioscience, CAT#L-2516) |
| 16:0 LPG (Echelon Bioscience, CAT#L-5216) |
| 16:0 LPThr (Echelon Bioscience, CAT#L-3316) |
| 18:1 LysoPEth (Echelon Bioscience, CAT#L-6030) |
| 18:2 LysoPC (Echelon Bioscience, CAT#L-1520) |
| 1D-O-(1,2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol (Echelon Bioscience, CAT#P-3S18) |
| 1R,2R-B13 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0042) |
| 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) (Echelon Bioscience, CAT#B-0031) |
| 2-C-Methyl-D-erythritol 2,4-cyclophosphate (Echelon Bioscience, CAT#I-M054) |
| 2-C-Methyl-D-erythritol 4-phosphate (MEP) (Echelon Bioscience, CAT#I-M051) |
| 2-C-Methyl-erythritol (ME) (Echelon Bioscience, CAT#I-M051A) |
| 2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-12) |
| 2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-11) |
| 2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-10) |
| 2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (Echelon Bioscience, CAT#Q-M1396) |
| 2,3-Oxidosqualene (racemic) (Echelon Bioscience, CAT#S-0301) |
| 2,3,22,23-Dioxidosqualene (Echelon Bioscience, CAT#S-0302) |
| 2,3,5-Tri-O-butyryl-Ins(1,4,6)P3/AM (Echelon Bioscience, CAT#Q-M0146) |
| 2S-OMPT (Echelon Bioscience, CAT#L-9418) |
| 2Z,6Z-Farnesol (Echelon Bioscience, CAT#S-0170) |
| 2Z,6Z-Farnesyl Diphosphate (Echelon Bioscience, CAT#I-0170) |
| 3-a-Aminocholestane (3AC, SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0341) |
| 3,3′-Bisoleoyl-LBPA tetrabutylammonium salt (Echelon Bioscience, CAT#L-B182) |
| 3C-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3C916) |
| 3C-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3C908) |
| 3S-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3S916) |
| 3S-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3S908) |
| 4-Demethylaminosancycline (CMT-3) (Echelon Bioscience, CAT#B-0802) |
| 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) (Echelon Bioscience, CAT#I-M052) |
| 4-Methylumbelliferone (Echelon Bioscience, CAT#JK201388) |
| 5-Ketoclomazone (DXP Synthase Inhibitor) (Echelon Bioscience, CAT#B-4101) |
| 5′ PtdIns(3,4,5)P3 Phosphatase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1400) |
| 6-O-palmitoyl-L-ascorbic acid (HAse Inhibitor) (Echelon Bioscience, CAT#B-0601) |
| 7-azido-4-methylcoumarin (AzMC, Hydrogen sulfide detector) (Echelon Bioscience, CAT#D-0010) |
| 9-tert-Butyl Doxycycline HCl (Echelon Bioscience, CAT#B-0801) |
| 9(10)-Nitrooleic Acid (Echelon Bioscience, CAT#L-0112) |
| 9Z-Octadecenyl phosphate (Echelon Bioscience, CAT#L-0418) |
| a-Secretase Substrate (Echelon Bioscience, CAT#640-55) |
| ABC294640 (SPHK2 Inhibitor) (Echelon Bioscience, CAT#B-0025) |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate) (Echelon Bioscience, CAT#855-46) |
| Ac-Ala-Arg-AMC (Echelon Bioscience, CAT#877-13) |
| Ac-Ala-Glu-Val-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-65) |
| Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor) (Echelon Bioscience, CAT#864-65) |
| Ac-Ala-Glu-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-65) |
| Ac-Arg-Ala-Arg-AMC (Echelon Bioscience, CAT#855-71) |
| Ac-Arg-Ala-Val-AMC (Echelon Bioscience, CAT#877-08) |
| Ac-Arg-Gly-Phe-Phe-Pro-AFC (Cathepsin D Substrate, fluorogenic) (Echelon Bioscience, CAT#874-19) |
| Ac-Arg-Gly-Phe-Phe-Pro-AMC (Echelon Bioscience, CAT#877-06) |
| Ac-Arg-Leu-Arg-AMC (Echelon Bioscience, CAT#920-75) |
| Ac-Arg-Ser-Leu-Lys-AMC (Site 1 Protease Substrate, fluorogenic) (Echelon Bioscience, CAT#877-09) |
| Ac-Asp-Gln-Met-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-26) |
| Ac-Asp-Gln-Met-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-22) |
| Ac-Asp-Glu-Val-Asp-4MbNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#861-18) |
| Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-18) |
| Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-20) |
| Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-30) |
| Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-28) |
| Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-25) |
| Ac-DEVD-AFC, (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-17) |
| Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor (Echelon Bioscience, CAT#864-20) |
| Ac-Glu-Ser-Met-Asp-AFC (Procaspase 3 Substrate, fluorogenic) (Echelon Bioscience, CAT#880-22) |
| Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor) (Echelon Bioscience, CAT#864-22) |
| Ac-Glu-Val-Asn-Leu-AMC (Echelon Bioscience, CAT#877-11) |
| Ac-Glu-Val-Asn-Leu-pNA (Echelon Bioscience, CAT#876-06) |
| Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide) (Echelon Bioscience, CAT#866-12) |
| Ac-Ile-Glu-Pro-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-30) |
| Ac-Ile-Glu-Pro-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-69) |
| Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#865-30) |
| Ac-Ile-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-58) |
| Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-58) |
| Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II) (Echelon Bioscience, CAT#860-59) |
| Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-56) |
| Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate) (Echelon Bioscience, CAT#860-43) |
| Ac-Leu-Glu-Glu-Asp-AFC (Caspase 13 Substrate) (Echelon Bioscience, CAT#863-55) |
| Ac-Leu-Glu-Glu-Asp-AMC (Caspase 13 Substrate) (Echelon Bioscience, CAT#862-55) |
| Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor) (Echelon Bioscience, CAT#864-85) |
| Ac-Leu-Glu-Glu-Asp-pNA (Caspase 13 Substrate) (Echelon Bioscience, CAT#861-85) |
| Ac-Leu-Glu-His-Asp-AFC (Caspase 9 Substrate) (Echelon Bioscience, CAT#863-40) |
| Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-45) |
| Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor) (Echelon Bioscience, CAT#864-45) |
| Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-47) |
| Ac-Leu-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-44) |
| Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor) (Echelon Bioscience, CAT#864-44) |
| Ac-Leu-Glu-Val-Asp-AFC (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#863-42) |
| Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate) (Echelon Bioscience, CAT#860-49) |
| Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor) (Echelon Bioscience, CAT#864-42) |
| Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#860-42) |
| Ac-Leu-Leu-Arg-AMC (Echelon Bioscience, CAT#877-12) |
| Ac-Leu-Leu-Tyr-AFC (Echelon Bioscience, CAT#875-20) |
| Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II) (Echelon Bioscience, CAT#866-39) |
| Ac-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphthylamide (Echelon Bioscience, CAT#878-02) |
| Ac-Lys-Pro-Arg-AMC (Echelon Bioscience, CAT#877-07) |
| Ac-Orn-Phe-Arg-AMC (Tryptase Substrate, fluorogenic) (Echelon Bioscience, CAT#871-94) |
| Ac-Phe-Ser-Arg-pNA (Echelon Bioscience, CAT#876-01) |
| Ac-Thr-Gln-Thr-Asp-AFC (DRONC Substrate) (Echelon Bioscience, CAT#850-16) |
| Ac-Thr-Gln-Thr-Glu-AFC (DRONC Substrate I) (Echelon Bioscience, CAT#850-17) |
| Ac-Trp-Glu-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-61) |
| Ac-Trp-Glu-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-63) |
| Ac-Trp-Glu-His-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#863-63) |
| Ac-Trp-Glu-His-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-60) |
| Ac-Trp-Glu-His-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-66) |
| Ac-Trp-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-64) |
| Ac-Trp-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-66) |
| Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-41) |
| Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-17) |
| Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-16) |
| Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-15) |
| Ac-Val-Ala-Asp-4MbNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#863-12) |
| Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-12) |
| Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor) (Echelon Bioscience, CAT#864-12) |
| Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-11) |
| Ac-Val-Asn-Leu-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-70) |
| Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-44) |
| Ac-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-48) |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-48) |
| Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor) (Echelon Bioscience, CAT#864-46) |
| Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-46) |
| Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-54) |
| Ac-Val-Glu-His-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-74) |
| Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-52) |
| Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor) (Echelon Bioscience, CAT#860-57) |
| Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-50) |
| Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-26) |
| Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-72) |
| Ac-VEID-AFC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#863-52) |
| Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor (Echelon Bioscience, CAT#864-15) |
| Acetyl Calcitonin, salmon (Echelon Bioscience, CAT#237-36) |
| Acetyl-Beta Amyloid (25-35) (Echelon Bioscience, CAT#641-59) |
| Acetyl-Neurotensin (8-13) (Echelon Bioscience, CAT#631-41) |
| Acid Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-3200) |
| ACTH (1-17), human (Echelon Bioscience, CAT#111-75) |
| ACTH (1-24), human (Echelon Bioscience, CAT#111-36) |
| ACTH (1-39), rat (Echelon Bioscience, CAT#115-10) |
| ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human (Echelon Bioscience, CAT#111-45) |
| Activity Dependant Neuroprotective Protein (74-81) (mouse, rat) (Echelon Bioscience, CAT#878-03) |
| ADAM substrate (Echelon Bioscience, CAT#825-15) |
| Adamantaneacetyl-Bradykinin [DArg0,Hyp3,Thi5,8,DPhe7] (Echelon Bioscience, CAT#191-84) |
| Adrenal Secretogranin, bovine (Echelon Bioscience, CAT#313-20) |
| Adrenomedullin (1-50), rat (Echelon Bioscience, CAT#335-75) |
| Adrenomedullin (1-52), human (Echelon Bioscience, CAT#331-80) |
| Adrenomedullin (11-50), rat (Echelon Bioscience, CAT#335-80) |
| Adrenomedullin (22-52), human (Echelon Bioscience, CAT#331-82) |
| Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 (Echelon Bioscience, CAT#429-15) |
| Akt Substrate (Echelon Bioscience, CAT#868-15) |
| Alkyl-OMPT (Echelon Bioscience, CAT#L-9518) |
| Allatostatin B2, cockroach (Echelon Bioscience, CAT#781-20) |
| Alpha MSH [D-Phe7] (Echelon Bioscience, CAT#570-42) |
| Alpha MSH [Nle4,D-Phe7] (Echelon Bioscience, CAT#570-43) |
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide (Echelon Bioscience, CAT#571-49) |
| AMARA peptide substrate (Echelon Bioscience, CAT#890-23) |
| Aminocardiolipin (Amino-CL) (Echelon Bioscience, CAT#L-C16A) |
| Amylin (1-37), human, amide (Echelon Bioscience, CAT#641-50) |
| Amyloid Blocker (Echelon Bioscience, CAT#641-81) |
| Amyloid Fragment (Pro18,Asp21) (17-21) (Echelon Bioscience, CAT#641-64) |
| Angiotensin (1-5) (Echelon Bioscience, CAT#131-53) |
| Angiotensin (1-7) (Echelon Bioscience, CAT#131-41) |
| Angiotensin I (1-9), DRVYIHPFH-OH (Echelon Bioscience, CAT#131-55) |
| Angiotensin I (human) (Echelon Bioscience, CAT#131-25) |
| Angiotensin I [Asn1,Val5,Asn9], salmon (Echelon Bioscience, CAT#137-40) |
| Angiotensin I [Asn1,Val5], goosefish (Echelon Bioscience, CAT#137-39) |
| Angiotensin I [Val5,Asn9], bullfrog (Echelon Bioscience, CAT#137-36) |
| Angiotensin II Antipeptide (Echelon Bioscience, CAT#131-64) |
| Angiotensin II-[Sar1] (Echelon Bioscience, CAT#131-65) |
| Angiotensin II, human (Echelon Bioscience, CAT#131-49) |
| Angiotensin III, human / Angiotensin II-[Des Asp1] (Echelon Bioscience, CAT#131-76) |
| Angiotensinogen (1-14) Renin Substrate, porcine (Echelon Bioscience, CAT#131-82) |
| Anti human Vps34 Antibody (Echelon Bioscience, CAT#Z-R016) |
| Anti-hVps34 Antibody for IP (Echelon Bioscience, CAT#Z-R015) |
| Anti-PEth Autologous IgG ELISA (Echelon Bioscience, CAT#K-5000A) |
| Anti-PtdIns(3,4,5)P3 IgM HRP (Echelon Bioscience, CAT#Z-H345) |
| Anti-PtdIns(3,4,5)P3 IgM In Ascities (Echelon Bioscience, CAT#Z-A345) |
| Anti-PtdIns(4,5)P2 IgM In Ascites (Echelon Bioscience, CAT#Z-A045) |
| Anti-Rat F1-ATP Synthase Alpha Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPA) |
| Anti-Rat F1-ATP Synthase Beta Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPB) |
| Antibody Sample Pack (Echelon Bioscience, CAT#Z-P100) |
| AP-811 (NPR-C receptor ligand) (Echelon Bioscience, CAT#492-10) |
| Apamin, bee venom (SS1-11, SS3-15) (Echelon Bioscience, CAT#425-10) |
| APP Beta Secretase Inhibitor (Echelon Bioscience, CAT#649-10) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-22) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-23) |
| Arachidonoyl LPA, 20:4 LPA (Echelon Bioscience, CAT#L-0204) |
| Arachidoyl LPA, 20:0 LPA (Echelon Bioscience, CAT#L-0200) |
| Arg-Gly-Asp-Ser (RGDS) (Echelon Bioscience, CAT#450-29) |
| ARN14988 (aCDase Inhibitor) (Echelon Bioscience, CAT#B-0041) |
| AS1938909 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0343) |
| AS1949490 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0342) |
| AS604850 (PI3-K gamma Inhibitor 2) (Echelon Bioscience, CAT#B-0302) |
| AS605240 (PI3-K gamma Inhibitor 1) (Echelon Bioscience, CAT#B-0301) |
| Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human (Echelon Bioscience, CAT#151-25) |
| Atrial Natriuretic Peptide (1-28), rat (Echelon Bioscience, CAT#155-56) |
| Atrial Natriuretic Peptide (4-28), rat / Auriculin B (Echelon Bioscience, CAT#155-62) |
| Atrial Natriuretic Peptide (ANP) (4-24), frog (Echelon Bioscience, CAT#153-15) |
| Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat (Echelon Bioscience, CAT#155-40) |
| Atriopeptin III, rat [ANP (127-150), rat] (Echelon Bioscience, CAT#155-63) |
| ATX Sandwich ELISA Assay Service (Echelon Bioscience, CAT#T-5600) |
| ATX-Red AR-2 (Echelon Bioscience, CAT#L-2010) |
| Autocamptide-2 Related Inhibitoy Peptide (Echelon Bioscience, CAT#891-24) |
| Autocamtide-2 Related Inhibitory Peptide, myristoylated (Echelon Bioscience, CAT#891-26) |
| Autotaxin Activity Assay (Echelon Bioscience, CAT#K-4100) |
| Autotaxin Activity Assay Service (Echelon Bioscience, CAT#T-4100) |
| Autotaxin Enzyme, active (Echelon Bioscience, CAT#E-4000) |
| Autotaxin Inhibitor Screening Assay Service (Echelon Bioscience, CAT#T-4200) |
| Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200) |
| Autotaxin Sandwich ELISA Kit (Echelon Bioscience, CAT#K-5600) |
| BAM (6-22) Bovine Adrenal Medulla Peptide (6-22) (Echelon Bioscience, CAT#313-64) |
| BAM 3200 Bovine Adrenal Medulla Peptide E (Echelon Bioscience, CAT#313-65) |
| Benzo[a]pyrene (Echelon Bioscience, CAT#B-0050) |
| Beta Amyloid (25-35), human (Echelon Bioscience, CAT#641-40) |
| Beta Amyloid [Glu11] (10-16), human (Echelon Bioscience, CAT#641-45) |
| Beta Amyloid [Nle35] (1-40), human (Echelon Bioscience, CAT#641-13) |
| Beta Amyloid (1-16) [Gln11], human (Echelon Bioscience, CAT#641-35) |
| Beta Amyloid (1-16), rat (Echelon Bioscience, CAT#642-36) |
| Beta Amyloid (1-28), [Gln11], human (Echelon Bioscience, CAT#641-17) |
| Beta Amyloid (1-28), rat (Echelon Bioscience, CAT#642-18) |
| Beta Amyloid (1-40), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-14) |
| Beta Amyloid (1-40), rat (Echelon Bioscience, CAT#642-10) |
| Beta Amyloid (1-42), human (Echelon Bioscience, CAT#641-15) |
| Beta Amyloid (1-42), human – HFIP (Echelon Bioscience, CAT#641-00) |
| Beta Amyloid (1-42), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-22) |
| Beta Amyloid (1-42), rat (Echelon Bioscience, CAT#642-15) |
| Beta Amyloid (10-20), human (Echelon Bioscience, CAT#641-21) |
| Beta Amyloid (12-28), human (Echelon Bioscience, CAT#641-19) |
| Beta Amyloid (13-16), human (Echelon Bioscience, CAT#641-88) |
| Beta Amyloid (16-10), reverse, human (Echelon Bioscience, CAT#641-54) |
| Beta Amyloid (17-42), human (Echelon Bioscience, CAT#641-90) |
| Beta Amyloid (22-35), human (Echelon Bioscience, CAT#641-44) |
| Beta Amyloid (25-35) [Ala28] (Echelon Bioscience, CAT#640-19) |
| Beta Amyloid (25-35) [Gly35] (Echelon Bioscience, CAT#640-21) |
| Beta Amyloid (25-35) [Nle35], human (Echelon Bioscience, CAT#641-53) |
| Beta Amyloid (26-35), human (Echelon Bioscience, CAT#641-41) |
| Beta Amyloid (27-35), human (Echelon Bioscience, CAT#641-42) |
| Beta Amyloid (28-35), human (Echelon Bioscience, CAT#641-43) |
| Beta Amyloid (35-25), reverse, human (Echelon Bioscience, CAT#641-47) |
| Beta Amyloid (40-1), reverse, human (Echelon Bioscience, CAT#641-70) |
| Beta Amyloid (42-1) reverse, human (Echelon Bioscience, CAT#641-69) |
| Beta Amyloid [Gln 22] (1-40), human (Echelon Bioscience, CAT#640-20) |
| Beta Amyloid [Gln 22] (1-42), human (Echelon Bioscience, CAT#642-30) |
| Beta Amyloid [Gln11] (1-40) , human (Echelon Bioscience, CAT#641-11) |
| Beta Amyloid [Glp3] (3-42), human (Echelon Bioscience, CAT#641-16) |
| Beta Amyloid [Glu11] (1-16) (Echelon Bioscience, CAT#641-36) |
| Beta Amyloid [Glu11] (1-38), human (Echelon Bioscience, CAT#641-25) |
| Beta Amyloid [Glu11] (1-40), human (Echelon Bioscience, CAT#641-10) |
| Beta Amyloid [Glu11] (1-40), human – HFIP (Echelon Bioscience, CAT#641-01) |
| Beta Amyloid [Glu11], (1-28), human (Echelon Bioscience, CAT#641-18) |
| Beta Endorphin, human / Beta Lipotropin (61-91), human (Echelon Bioscience, CAT#291-25) |
| Beta MSH, human (Echelon Bioscience, CAT#571-47) |
| Beta Secretase Inhibitor II (Echelon Bioscience, CAT#649-18) |
| Big Endothelin (1-38), human (Echelon Bioscience, CAT#331-30) |
| Big Endothelin (1-39), porcine (Echelon Bioscience, CAT#334-10) |
| Big Endothelin (1-39), rat (Echelon Bioscience, CAT#335-50) |
| Big Endothelin 1 [D-Val22] (16-38), human (Echelon Bioscience, CAT#331-32) |
| Big Endothelin 2 (1-37), human (Echelon Bioscience, CAT#331-40) |
| Big Gastrin, sulfated (Echelon Bioscience, CAT#471-80) |
| Bilirubin (Echelon Bioscience, CAT#F-H120) |
| Bilirubin Conjugate (Echelon Bioscience, CAT#F-H130) |
| Bilirubin dimethyl ester (Echelon Bioscience, CAT#F-H110) |
| Biliverdin Hydrochloride (Echelon Bioscience, CAT#F-H100) |
| Biotin 18:0 LysoPC (Echelon Bioscience, CAT#L-15B18) |
| Biotin Monolysocardiolipin (Echelon Bioscience, CAT#L-M16B) |
| Biotin Phosphatidylinositol (Echelon Bioscience, CAT#C-00B6) |
| Biotin Phosphatidylinositol 3-phosphate (Echelon Bioscience, CAT#C-03B6) |
| Biotin Phosphatidylinositol 3,4-bisphosphate (Echelon Bioscience, CAT#C-34B6) |
| Biotin Phosphatidylinositol 3,5-bisphosphate (Echelon Bioscience, CAT#C-35B6) |
| Biotin Phosphatidylinositol 4-phosphate (Echelon Bioscience, CAT#C-04B6) |
| Biotin Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45B6) |
| Biotin Phosphatidylinositol 5-phosphate (Echelon Bioscience, CAT#C-05B6) |
| Biotin PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6) |
| Biotin Sphingomyelin (Echelon Bioscience, CAT#S-400B) |
| biotin-C12-ether LBPA (Echelon Bioscience, CAT#L-B1B12) |
| Biotin-Cardiolipin (Echelon Bioscience, CAT#L-C16B) |
| Biotin-Ceramide (Echelon Bioscience, CAT#S-300B) |
| Biotin-Lactosylceramide (Echelon Bioscience, CAT#S-600B) |
| Biotin-monolysocardiolipin (Echelon Bioscience, CAT#L-MB16) |
| Biotin-Phosphatidic Acid (Echelon Bioscience, CAT#L-41B16) |
| Biotin-Phosphatidylcholine (Echelon Bioscience, CAT#L-11B16) |
| Biotin-Phosphatidylethanol (12:0/18:1) (Echelon Bioscience, CAT#L-60B18) |
| Biotin-Phosphatidylethanol (6:0/16:0) (Echelon Bioscience, CAT#L-60B16) |
| Biotin-Phosphatidylethanolamine (Echelon Bioscience, CAT#L-21B6) |
| Biotin-Phosphatidylglycerol (Echelon Bioscience, CAT#L-51B16) |
| Biotin-Phosphatidylserine (Echelon Bioscience, CAT#L-31B16) |
| Biotinyl-alpha MSH [Nle4,DPhe7] (Echelon Bioscience, CAT#570-46) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-B345B) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-B345) |
| Biotinylated Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-B034) |
| Biotinylated Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-B045) |
| Biotinylated Select-HA 1000k (Echelon Bioscience, CAT#HYA-B1000-200) |
| Biotinylated Select-HA 250k (Echelon Bioscience, CAT#HYA-B250-200) |
| Biotinylated Select-HA 500k (Echelon Bioscience, CAT#HYA-B500-200) |
| Biotinylated Select-HA 50k (Echelon Bioscience, CAT#HYA-B50-200) |
| Biotinylated Versican G1 Domain (Echelon Bioscience, CAT#G-HA02) |
| Bisepoxy Juvenile Hormone III (Echelon Bioscience, CAT#S-0157) |
| BOC-Lys(Ac)-AMC (Histone Deacetylase (HDAC) Substrate) (Echelon Bioscience, CAT#888-20) |
| Boc-Val-Gly-Arg-bNA (Plasminogen Activator Substrate) (Echelon Bioscience, CAT#875-17) |
| BOC-Val-Pro-Arg-AFC (Thrombin substrate, fluorogenic) (Echelon Bioscience, CAT#885-11) |
| BODIPY FL Phosphatidylinositol (Echelon Bioscience, CAT#C-00F6) |
| BODIPY FL Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45F6) |
| BODIPY FL PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6) |
| BODIPY FL PI(3,4)P2 (Echelon Bioscience, CAT#C-34F6) |
| BODIPY FL PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6) |
| BODIPY FL PI(3)P (Echelon Bioscience, CAT#C-03F6) |
| BODIPY FL PI(4)P (Echelon Bioscience, CAT#C-04F6) |
| BODIPY FL PI(5)P (Echelon Bioscience, CAT#C-05F6) |
| Bodipy Labeled PIP Sample Pack (Echelon Bioscience, CAT#C-99F6) |
| BODIPY TMR Phosphatidylinositol (Echelon Bioscience, CAT#C-00M6) |
| BODIPY TMR PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6) |
| BODIPY TMR PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6) |
| BODIPY TMR PI(3,5)P2 (Echelon Bioscience, CAT#C-35M6) |
| BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6) |
| BODIPY TMR PI(4,5)P2 (Echelon Bioscience, CAT#C-45M6) |
| BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6) |
| BODIPY TMR PI(5)P (Echelon Bioscience, CAT#C-05M6) |
| BODIPY-FL PEth (Echelon Bioscience, CAT#L-60F18) |
| Bombesin (Echelon Bioscience, CAT#177-25) |
| Bovine Adrenal Medulla Docosapeptide / BAM 22P (Echelon Bioscience, CAT#313-45) |
| Bovine Thrombin (Echelon Bioscience, CAT#E-9000) |
| Bradykinin (1-7) (Echelon Bioscience, CAT#191-72) |
| Bradykinin (1-9) (Echelon Bioscience, CAT#191-25) |
| Bradykinin B2 Antagonist (HOE 140) (Echelon Bioscience, CAT#191-85) |
| Bradykinin Ile-Ser, (T-Kinin) (Echelon Bioscience, CAT#191-49) |
| Bradykinin Potentiating Factor (Angiotensin Converting Enzyme Inhibitor) (Echelon Bioscience, CAT#131-95) |
| Brain Derived Acidic Fibroblast Growth Factor (1-11), bovine (Echelon Bioscience, CAT#510-42) |
| Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human (Echelon Bioscience, CAT#152-52) |
| BrP-LPA (Echelon Bioscience, CAT#L-7416) |
| C-Peptide [Tyr0] / Proinsulin (32-63) Tyr0 (Echelon Bioscience, CAT#211-27) |
| C-Type Natriuretic Peptide (CNP) (1-22), human (Echelon Bioscience, CAT#151-60) |
| C6NIB (H2O2 vapor sensor) (Echelon Bioscience, CAT#D-0020) |
| Caerulein (ceruletide) (Echelon Bioscience, CAT#471-65) |
| Calcitonin Gene Related Peptide (CGRP), human (Echelon Bioscience, CAT#231-27) |
| Calcitonin Gene Related Peptide I (8-37), human / CGRP Receptor Antagonist (Echelon Bioscience, CAT#231-31) |
| Calcitonin Gene Related Peptide II (8-37), human / Beta CGRP (Echelon Bioscience, CAT#231-22) |
| Calcitonin Gene Related Peptide II (CGRP II, human), cyclic (Echelon Bioscience, CAT#231-29) |
| Calcitonin, human, cyclic (Echelon Bioscience, CAT#231-25) |
| Calcitonin, salmon (Echelon Bioscience, CAT#237-26) |
| Calcitonin, salmon [Des-Cys1] (Echelon Bioscience, CAT#237-34) |
| Calcitonin, salmon [Des-Tyr22] (Echelon Bioscience, CAT#237-32) |
| Calmodulin Binding Domain Ca2+/Calmodulin Dependent Protein (Echelon Bioscience, CAT#740-60) |
| Calmodulin Dependent Protein Kinase Substrate (Echelon Bioscience, CAT#890-81) |
| Calmodulin Kinase II Inhibitor (281-309) (Echelon Bioscience, CAT#893-40) |
| Calpastatin Peptide (Ac 184-210 ) (Echelon Bioscience, CAT#870-20) |
| cAMP Dependent Protein Kinase Inhibitor 5-24 amide (Echelon Bioscience, CAT#891-14) |
| cAMP Dependent Protein Kinase Inhibitor PKI-tide (Echelon Bioscience, CAT#892-20) |
| Cardioexcitatory Peptide, African giant snail (Echelon Bioscience, CAT#610-74) |
| Cardiolipin Beads (Echelon Bioscience, CAT#P-BCLP) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-56) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-52) |
| Cathepsin D and E substrate, fluorogenic (Echelon Bioscience, CAT#866-41) |
| Cathepsin D Substrate (Echelon Bioscience, CAT#880-42) |
| Cathepsin L Inhibitor (Echelon Bioscience, CAT#866-23) |
| Cathepsin S Substrate, fluorogenic (Echelon Bioscience, CAT#866-80) |
| CDP-ME Kinase (IspE) (Echelon Bioscience, CAT#E-2000E) |
| CDP-ME Synthase (IspD) (Echelon Bioscience, CAT#E-2000D) |
| CDP-ME Synthase (IspD) Enzymatic Assay (Echelon Bioscience, CAT#K-2000D) |
| CDP-MEP Synthesis Kit (Echelon Bioscience, CAT#K-2000E) |
| Cecropin B (Echelon Bioscience, CAT#893-50) |
| Cecropin P1, porcine (Echelon Bioscience, CAT#893-60) |
| Cell Adhesion Inhibitor Peptide, cyclic (Echelon Bioscience, CAT#451-40) |
| Cell Permeable Caspase 1 Inhibitor (Echelon Bioscience, CAT#864-38) |
| Cell Permeable Caspase 3 Inhibitor (Echelon Bioscience, CAT#864-29) |
| Cell Permeable Caspase 6 Inhibitor (Echelon Bioscience, CAT#864-31) |
| Ceramide 1-Phosphate (C1P) Beads (Echelon Bioscience, CAT#P-BC1P) |
| Ceramide Beads (Echelon Bioscience, CAT#P-BCER) |
| Ceranib-2 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0043) |
| cGMP Dep. Protein Kinase Substrate (BPDEide) (Echelon Bioscience, CAT#870-78) |
| Charybdotoxin, cyclic (Echelon Bioscience, CAT#429-60) |
| Chemotactic Peptide (Formyl-Met-Leu-Phe-OH) (Echelon Bioscience, CAT#850-15) |
| Chitin Polymer (Echelon Bioscience, CAT#H-10CH) |
| Cholecystokinin Octapeptide (26-33) / CCK 8 (Echelon Bioscience, CAT#471-47) |
| Cholecystokinin Octapeptide (26-33) Non-Sulfated / CCK-NSE O (Echelon Bioscience, CAT#471-48) |
| Cholesterol (Echelon Bioscience, CAT#L-6012) |
| Cholesterol Beads (Echelon Bioscience, CAT#P-BCHL) |
| Chromogranin A (324-337) WE 14, human (Echelon Bioscience, CAT#474-70) |
| Cionin (Echelon Bioscience, CAT#477-49) |
| Class I PI3-Kinase Reaction Buffer (Echelon Bioscience, CAT#K-KBZ) |
| Class III PI3K ELISA Kit (Echelon Bioscience, CAT#K-3000) |
| cMEPP Synthase (IspF) (Echelon Bioscience, CAT#E-2000F) |
| CML ELISA Kit II (Echelon Bioscience, CAT#K-3900S) |
| Coagulation Factor XIIIA (72-97) (Echelon Bioscience, CAT#459-15) |
| Colipase Activation Peptide (Echelon Bioscience, CAT#873-30) |
| Collagen Hybridizing Peptide – Biotin conjugate (CHP) (Echelon Bioscience, CAT#BIO) |
| Collagen Hybridizing Peptide – Cy3 Conjugate (Echelon Bioscience, CAT#RED) |
| Collagen Hybridizing Peptide – Fluorescein Conjugate (Echelon Bioscience, CAT#FLU) |
| Control Beads (Echelon Bioscience, CAT#P-B000) |
| Control PolyPIPosomes (Echelon Bioscience, CAT#Y-0000) |
| Corazonin, Periplaneta Americana (Echelon Bioscience, CAT#619-47) |
| Corticotropin Releasing Factor (CRF) human, rat (Echelon Bioscience, CAT#351-25) |
| Corticotropin Releasing Factor [Tyr0], ovine / CRF [Tyr0], o (Echelon Bioscience, CAT#352-37) |
| Corticotropin Releasing Factor, bovine, CRF, bovine (Echelon Bioscience, CAT#353-26) |
| Corticotropin Releasing Factor, ovine / CRF, ovine (Echelon Bioscience, CAT#352-26) |
| Cova PIP Screening Plate (Echelon Bioscience, CAT#H-6200) |
| CREBtide (Echelon Bioscience, CAT#890-15) |
| Cu(II) Protoporphyrin IX, 14494-37-2 (Echelon Bioscience, CAT#F-H070) |
| Custom Lipid Array Strip (Echelon Bioscience, CAT#P-6111) |
| CYM50308 (S1P4 Receptor Agonist) (Echelon Bioscience, CAT#B-0060) |
| D-erythro-Sphingosine (Echelon Bioscience, CAT#S-1000) |
| D-Ile-Pro-Arg-AMC (Echelon Bioscience, CAT#855-18) |
| D-Ile-Pro-Arg-pNA (Echelon Bioscience, CAT#855-19) |
| D-Phe-Pro-Lys-pNA (Thrombin Substrate colorimetric) (Echelon Bioscience, CAT#885-49) |
| D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT) (Echelon Bioscience, CAT#L-9318) |
| D-Val-Gly-Arg-pNA (Echelon Bioscience, CAT#855-31) |
| D-Val-Leu-Arg-AFC (Kallikrein substrate, fluorogenic) (Echelon Bioscience, CAT#871-84) |
| D-Val-Leu-Arg-AMC (Kallikrein Substrate, fluorogenic) (Echelon Bioscience, CAT#871-81) |
| D-Val-Leu-Arg-pNA (Kallikrein Substrate, colorimetric) (Echelon Bioscience, CAT#871-82) |
| D-Val-Leu-Lys-AFC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-22) |
| D-Val-Leu-Lys-AMC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-18) |
| D-Val-Leu-Lys-pNA (Plasmin substrate colorimetric) (Echelon Bioscience, CAT#872-21) |
| D-Val-Lys-Lys-Arg-AMC (Echelon Bioscience, CAT#855-44) |
| d5-PAPEth (Echelon Bioscience, CAT#L-6055) |
| d5-PLPEth (Echelon Bioscience, CAT#L-6052) |
| d5-POPEth (Echelon Bioscience, CAT#L-6051) |
| d5-SLPEth (Echelon Bioscience, CAT#L-6054) |
| d5-SOPEth (Echelon Bioscience, CAT#L-6053) |
| DAPC (20:0 PC) (Echelon Bioscience, CAT#L-1120) |
| DBPC (PLA2 Substrate) (Echelon Bioscience, CAT#L-3000) |
| Decorsin, Leech (Macrobdella decora) (Echelon Bioscience, CAT#459-10) |
| Decyl Rhamnoside (Echelon Bioscience, CAT#RL10-1) |
| Dermaseptin (Echelon Bioscience, CAT#889-15) |
| DES1 Inhibitor (Echelon Bioscience, CAT#B-0027) |
| Desmopressin, [D-Gln4] Disulfide Bridge 1-6, Acetate (Echelon Bioscience, CAT#671-18) |
| Desmopressin, [L-Arg8], Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-20) |
| Desmopressin, Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-19) |
| DHPS (6:0/6:0 PS) (Echelon Bioscience, CAT#L-3106) |
| Dibromobimane (Echelon Bioscience, CAT#F-0040) |
| Dilauroyl-sn-glycerol (Echelon Bioscience, CAT#L-0012) |
| Dimethylallyl Diphosphate (DMAPP) (Echelon Bioscience, CAT#I-0051) |
| Dimethylallyl S-Thiolodiphosphate (DMASPP) (Echelon Bioscience, CAT#I-S051) |
| Dimyristoyl-sn-glycerol (Echelon Bioscience, CAT#L-0014) |
| Dipalmitoyl-sn-glycerol (Echelon Bioscience, CAT#L-0016) |
| DLPA (12:0/12:0 PA) (Echelon Bioscience, CAT#L-4112) |
| DLPC (12:0/12:0 PC) (Echelon Bioscience, CAT#L-1112) |
| DLPE (12:0/12:0 PE) (Echelon Bioscience, CAT#L-2112) |
| DLPG (12:0/12:0 PG) (Echelon Bioscience, CAT#L-5112) |
| DMOG (dimethyloxalylglycine) (Echelon Bioscience, CAT#F-0010) |
| DMPA (14:0/14:0 PA) (Echelon Bioscience, CAT#L-4114) |
| DMPC (14:0/14:0 PC) (Echelon Bioscience, CAT#L-1114) |
| DMPE (14:0/14:0 PE) (Echelon Bioscience, CAT#L-2114) |
| DMPG (14:0/14:0 PG) (Echelon Bioscience, CAT#L-5114) |
| Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP 8 Substrate) (Echelon Bioscience, CAT#868-44) |
| Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate) (Echelon Bioscience, CAT#865-10) |
| DOPC (18:1/18:1 PC) (Echelon Bioscience, CAT#L-1182) |
| DOPE (18:1/18:1 PE) (Echelon Bioscience, CAT#L-2182) |
| DOPEth (18:1/18:1 PEth) (Echelon Bioscience, CAT#L-6018) |
| DPePC (Echelon Bioscience, CAT#L-1162) |
| DPPA (16:0/16:0 PA) (Echelon Bioscience, CAT#L-4116) |
| DPPC (16:0/16:0 PC) (Echelon Bioscience, CAT#L-1116) |
| DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2116) |
| DPPG (16:0/16:0 PG) (Echelon Bioscience, CAT#L-5116) |
| DPPS (16:0/16:0 PS) (Echelon Bioscience, CAT#L-3116) |
| DSPA (18:0/18:0 PA) (Echelon Bioscience, CAT#L-4118) |
| DSPC (18:0 PC) (Echelon Bioscience, CAT#L-1118) |
| DSPE (18:0/18:0 PE) (Echelon Bioscience, CAT#L-2118) |
| DSPG (18:0/18:0 PG) (Echelon Bioscience, CAT#L-5118) |
| DXP Synthase (DXS) (Echelon Bioscience, CAT#E-20DXS) |
| Dynorphin A (1-8), porcine (Echelon Bioscience, CAT#274-82) |
| Dynorphin A, porcine [Prodynorphin (209-225)] (Echelon Bioscience, CAT#274-27) |
| Dynorphin B, porcine / Rimorphin / Prodynorphin (228-240) (Echelon Bioscience, CAT#274-50) |
| ECE-1 Substrate (Echelon Bioscience, CAT#331-72) |
| Endomorphin I (Echelon Bioscience, CAT#311-88) |
| Endomorphin II (Echelon Bioscience, CAT#311-89) |
| Endothelin 2, human / ET 2 (Echelon Bioscience, CAT#331-20) |
| Endothelin 1, human (Echelon Bioscience, CAT#331-25) |
| Endothelin 3, cyclic (human, mouse, rabbit, rat) (Echelon Bioscience, CAT#335-10) |
| Endothelin Antagonist BQ 123, cyclic (Echelon Bioscience, CAT#331-10) |
| Endothelin Antagonist PD 142893 (Echelon Bioscience, CAT#331-17) |
| Endothelin Beta Receptor Agonist IRL 1620 (Echelon Bioscience, CAT#331-11) |
| Endothelin Beta Receptor Antagonist IRL 1038 (Echelon Bioscience, CAT#331-13) |
| Endothelin Receptor Antagonist BQ 3020 / Acetyl-(Ala11,15)-ET (Echelon Bioscience, CAT#331-14) |
| Endothelin Receptor Antagonist W 7338A (Echelon Bioscience, CAT#331-16) |
| Enkephalin Analog (Echelon Bioscience, CAT#311-55) |
| Enkephalinamide [D-Met2,Pro5] (Echelon Bioscience, CAT#310-47) |
| Epidermal Growth Factor (20-31) [Cys (Acm 20,31)] / EGF (Echelon Bioscience, CAT#510-50) |
| ET A Receptor Antagonist JKC 301 (Echelon Bioscience, CAT#331-51) |
| ET Antagonist PD 156252 (Echelon Bioscience, CAT#331-19) |
| ET Receptor Antagonist (PD 145065) (Echelon Bioscience, CAT#331-18) |
| Ether C12 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B120E) |
| Ether C18 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B180E) |
| Exendin 3 (Echelon Bioscience, CAT#507-79) |
| Exendin 3 (9-39) Fragment (Echelon Bioscience, CAT#507-81) |
| Exendin 4 (Echelon Bioscience, CAT#507-77) |
| ExoClean – EV Purification Kit (Echelon Bioscience, CAT#K-4300a) |
| ExoTracker – Membrane (Echelon Bioscience, CAT#K-4300b) |
| ExoTracker – RNA (Echelon Bioscience, CAT#K-4300c) |
| ExoTracker – Total (Echelon Bioscience, CAT#K-4300d) |
| Extracellular Death Factor (Echelon Bioscience, CAT#950-10) |
| Farnesyl Diphosphate (FPP) (Echelon Bioscience, CAT#I-0150) |
| Farnesyl S-Thiolodiphosphate (FSPP) (Echelon Bioscience, CAT#I-S150) |
| Fibrinogen Binding Inhibitory Peptide (Echelon Bioscience, CAT#431-55) |
| Fibrinogen Fragment (Echelon Bioscience, CAT#450-16) |
| Fibrinopeptide A [Tyr0], human (Echelon Bioscience, CAT#431-31) |
| Fibrinopeptide B [Glu1], (human) (Echelon Bioscience, CAT#431-39) |
| Fibrinopeptide B, human (Echelon Bioscience, CAT#431-36) |
| Fibronectin Fragment (Echelon Bioscience, CAT#450-59) |
| Flow PIPs: Multiplex Lipid Beads (Echelon Bioscience, CAT#P-FB01) |
| Fluorescein conjugated Anti-PI(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-G345) |
| Fluorescein conjugated Anti-PI(4,5)P2 IgM (Echelon Bioscience, CAT#Z-G045) |
| Fluorescein Monolysocardiolipin (Echelon Bioscience, CAT#L-M16F) |
| Fluorescent Carrier Pack (Echelon Bioscience, CAT#P-9CFL) |
| FPA-124 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0101) |
| FR-1, cyclic (Echelon Bioscience, CAT#450-53) |
| FR900098 (Echelon Bioscience, CAT#B-4202) |
| FS-3 (LysoPLD / Autotaxin substrate) (Echelon Bioscience, CAT#L-2000) |
| FTY720 (Echelon Bioscience, CAT#B-0720) |
| Furin Inhibitor II (Echelon Bioscience, CAT#855-10) |
| G-Subtide (Echelon Bioscience, CAT#871-15) |
| Galanin, rat (Echelon Bioscience, CAT#475-25) |
| Galanin, human (Echelon Bioscience, CAT#471-22) |
| Galanin, porcine (Echelon Bioscience, CAT#471-25) |
| Galantide (Echelon Bioscience, CAT#471-02) |
| Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-27) |
| Ganirelix (Echelon Bioscience, CAT#557-31) |
| Gastric Inhibitory Peptide (GIP), human (Echelon Bioscience, CAT#471-75) |
| Gastrin (1-17) [Gly18], human (Echelon Bioscience, CAT#471-89) |
| Gastrin (2-17) [Leu15,Gly18] / MSI 1771 (Echelon Bioscience, CAT#471-83) |
| Gastrin I (1-14) (Echelon Bioscience, CAT#471-79) |
| Gastrin I, human (Echelon Bioscience, CAT#471-73) |
| Gastrin II SE, human (Echelon Bioscience, CAT#471-74) |
| Gastrin Releasing Peptide, human / GRP, h (Echelon Bioscience, CAT#471-85) |
| Geranyl Diphosphate (GPP) (Echelon Bioscience, CAT#I-0100) |
| Geranyl S-Thiolodiphosphate (GSPP) (Echelon Bioscience, CAT#I-S100) |
| Geranylgeranyl Diphosphate (GGPP) (Echelon Bioscience, CAT#I-0200) |
| Geranylgeranyl S-thiodiphosphate (GGSPP) (Echelon Bioscience, CAT#I-S200) |
| Ghrelin (rat) (Echelon Bioscience, CAT#551-15) |
| Ghrelin, human (Echelon Bioscience, CAT#551-10) |
| GloPIPs Biotin-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6A) |
| GloPIPs Biotin-PI(3,4)P2 (Echelon Bioscience, CAT#C-34B6A) |
| GloPIPs Biotin-PI(3,5)P2 (Echelon Bioscience, CAT#C-35B6A) |
| GloPIPs Biotin-PI(3)P (Echelon Bioscience, CAT#C-03B6A) |
| GloPIPs Biotin-PI(4,5)P2 (Echelon Bioscience, CAT#C-45B6a) |
| GloPIPs Biotin-PI(4)P (Echelon Bioscience, CAT#C-04B6A) |
| GloPIPs Biotin-PI(5)P (Echelon Bioscience, CAT#C-05B6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3, C16 (Echelon Bioscience, CAT#C-39F16A) |
| GloPIPs BODIPY FL-PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2 (Echelon Bioscience, CAT#C-45F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2, C16 (Echelon Bioscience, CAT#C-45F16A) |
| GloPIPs BODIPY FL-PI(4)P (Echelon Bioscience, CAT#C-04F6A) |
| GloPIPs BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6A) |
| GloPIPs BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6A) |
| GloPIPs BODIPY TMR-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6A) |
| GloPIPs BODIPY TMR-PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2 (Echelon Bioscience, CAT#C-45M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2, C16 (Echelon Bioscience, CAT#C-45M16A) |
| GLP 2 [Gly2], human (Echelon Bioscience, CAT#471-21) |
| GLP 2 [Tyr34] (1-34), human (Echelon Bioscience, CAT#471-19) |
| GLP-1 (9-36) , Glucagon-like Peptide 1 (Echelon Bioscience, CAT#471-42) |
| Glp-Pro-Val-pNA (Human Granulocyte Elastase Substrate, colorimetric) (Echelon Bioscience, CAT#871-19) |
| Glu-His-Tyr-Gln-AMC (Echelon Bioscience, CAT#877-01) |
| Glucagon-like Peptide-1, GLP-1 (7-36) / Preproglucagon (78-107) amide (Echelon Bioscience, CAT#471-28) |
| Glucagon-like Peptide-1, GLP-1 (7-37) human (Echelon Bioscience, CAT#471-39) |
| Glucagon-like Peptide-1, GLP-1 (Preproglucagon 72-107) amide (Echelon Bioscience, CAT#471-27) |
| Glucagon-like Peptide-1, human (Echelon Bioscience, CAT#471-26) |
| Glucagon-like Peptide-2, GLP-2 (1-33), rat / Preproglucagon (126-158) (Echelon Bioscience, CAT#471-23) |
| Glucagon-like Peptide-2, GLP-2, human / Preproglucagon (126-158), human (Echelon Bioscience, CAT#471-18) |
| Glucagon, human (Echelon Bioscience, CAT#471-30) |
| Gly-Arg-Ala-Asp-Ser-Pro (GRADSP) (Echelon Bioscience, CAT#450-36) |
| Gly-Arg-Gly-Asp-Ser (GRGDS) (Echelon Bioscience, CAT#450-38) |
| Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Echelon Bioscience, CAT#450-39) |
| Gly-Pro-Arg-Pro-NH2 (Echelon Bioscience, CAT#450-17) |
| Glycerophosphoinositol 5-phosphate (Gro PI(5)P) (Echelon Bioscience, CAT#P-5000) |
| GMAP (1-41), amide / Galanin Message Associated Peptide (1-41), amide (Echelon Bioscience, CAT#421-35) |
| Goat anti-human Autotaxin antibody (Echelon Bioscience, CAT#Z-P400) |
| Granuliberin R (Echelon Bioscience, CAT#880-87) |
| Granzyme A Substrate, fluorogenic (Echelon Bioscience, CAT#874-13) |
| GRF (1-44)NH2, bovine (Echelon Bioscience, CAT#535-15) |
| GRF, mouse (Echelon Bioscience, CAT#536-10) |
| GRI977143 (LPA2 Agonist) (Echelon Bioscience, CAT#B-0070) |
| GroPI (Echelon Bioscience, CAT#P-0000) |
| GroPI(3,4,5)P3 (Echelon Bioscience, CAT#P-3900) |
| GroPI(4,5)P2 (Echelon Bioscience, CAT#P-4500) |
| GroPI(4)P (Echelon Bioscience, CAT#P-4000) |
| Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human (Echelon Bioscience, CAT#531-76) |
| Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human (Echelon Bioscience, CAT#531-74) |
| Growth Hormone Releasing Factor (1-29) amide, human / GRF (1-29), amide, human (Echelon Bioscience, CAT#531-75) |
| Growth Hormone Releasing Factor (1-40) amide, human; GRF (1-40) amide, human (Echelon Bioscience, CAT#531-67) |
| Growth Hormone Releasing Factor (1-40), human; GRF (1-40), human (Echelon Bioscience, CAT#531-68) |
| Growth Hormone Releasing Factor (1-44), porcine / GRF (1-44), porcine (Echelon Bioscience, CAT#534-29) |
| Growth Hormone Releasing Factor / GRF [Ac-Tyr1,D-Arg2] (1-29) amide (Echelon Bioscience, CAT#531-84) |
| Growth Hormone Releasing Factor, GRF (1-44) amide, human (Echelon Bioscience, CAT#531-66) |
| Growth Hormone Releasing Peptide 6 (GHRP-6) / GHRP [His1, Lys6] (Echelon Bioscience, CAT#531-18) |
| HA130 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0701) |
| HA30-BODIPY-FL (Echelon Bioscience, CAT#H-025F) |
| HA30-TexasRed (Echelon Bioscience, CAT#H-025R) |
| HA300-BODIPY-FL (Echelon Bioscience, CAT#H-250F) |
| HA300-TexasRed (Echelon Bioscience, CAT#H-250R) |
| HA850-BODIPY-FL (Echelon Bioscience, CAT#H-700F) |
| HA850-TexasRed (Echelon Bioscience, CAT#H-700R) |
| Helodermin [Gln8,9] (Echelon Bioscience, CAT#740-27) |
| Hemagglutination Inhibiting Peptide, human;from parotid secr (Echelon Bioscience, CAT#790-10) |
| Heme Oxygenase Inhibitor Toolbox (Echelon Bioscience, CAT#F-HOIT) |
| Hemin (Echelon Bioscience, CAT#F-H010) |
| Heparin ELISA (Echelon Bioscience, CAT#K-5300) |
| Hepatitis C Virus NS3 Protease Substrate, fluorogenic (Echelon Bioscience, CAT#732-35) |
| Herpes Virus Inhibitor 1 (Echelon Bioscience, CAT#732-36) |
| Herpes Virus Inhibitor 2 (Echelon Bioscience, CAT#872-39) |
| Hexadecyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0320) |
| High Mobility Group Box 1 (HMGB1) (Echelon Bioscience, CAT#G-HMGB1) |
| High Throughput Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200HTS) |
| Hirudin (54-65), Sulfated (Echelon Bioscience, CAT#873-20) |
| Hirudin Acetyl (54-65) Sulfated (Echelon Bioscience, CAT#873-15) |
| Histidine Tagged Versican G1 Domain (Echelon Bioscience, CAT#G-HA03) |
| Histone H2B (29-35) (Echelon Bioscience, CAT#870-75) |
| HIV Envelope Peptide GP 120, (307-330) (Echelon Bioscience, CAT#870-26) |
| HIV Substrate IV (Echelon Bioscience, CAT#870-15) |
| HIV-1 Protease Substrate (Echelon Bioscience, CAT#870-10) |
| HIV-TAT 48-57 JNK Inhibitor I (Echelon Bioscience, CAT#732-10) |
| HS014 / MSH Antagonist cyclic / File # 0045A (Echelon Bioscience, CAT#571-72) |
| Human Lysosomal Phospholipase A2 (hLPLA2), active (Echelon Bioscience, CAT#E-7000) |
| Humanin, human (Echelon Bioscience, CAT#640-52) |
| Hy-Pip Cova PIP Specificity Plate (Echelon Bioscience, CAT#H-6300) |
| Hyaluronan Enzyme-Linked Immunosorbent Assay (HA ELISA) (Echelon Bioscience, CAT#K-1200) |
| Hyaluronic Acid (HA) Screening Service (Echelon Bioscience, CAT#T-1200) |
| Hyaluronic Acid Sandwich ELISA (Echelon Bioscience, CAT#K-4800) |
| Hyaluronidase Activity ELISA (Echelon Bioscience, CAT#K-6000) |
| Hypertrehalosaemic Neuropeptide, german cockroach (Nauphoeta (Echelon Bioscience, CAT#619-58) |
| IC87114 (PI3-K delta inhibitor) (Echelon Bioscience, CAT#B-0305) |
| IGRP Catalytic Subunit (206-214) (Echelon Bioscience, CAT#471-58) |
| Innate Defense Regulator 1018 (IDR-1018) (Echelon Bioscience, CAT#745-20) |
| Inositol 1,2,6-trisphosphate (Ins(1,2,6)P3) (Echelon Bioscience, CAT#Q-0126) |
| Inositol 1,3-bisphosphate (Ins(1,3)P2) (Echelon Bioscience, CAT#Q-0013) |
| Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) (Echelon Bioscience, CAT#Q-0134) |
| Inositol 1,3,5-trisphosphate (Ins(1,3,5)P3) (Echelon Bioscience, CAT#Q-0135) |
| Inositol 1,4-bisphosphate (Ins(1,4)P2) (Echelon Bioscience, CAT#Q-0014) |
| Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Echelon Bioscience, CAT#Q-0145) |
| Inositol 1,5-bisphosphate (Ins(1,5)P2) (Echelon Bioscience, CAT#Q-0015) |
| INPP4 Activity Kit (Echelon Bioscience, CAT#K-5200) |
| INPP4A, active (Echelon Bioscience, CAT#E-8000) |
| Ins(1,3,4,5)P4 (Echelon Bioscience, CAT#Q-1345) |
| Ins(1,3,4,5)P4 Beads (Echelon Bioscience, CAT#Q-B1345) |
| Ins(1,3,4,5)P4 Biotin (Echelon Bioscience, CAT#Q-139B) |
| Ins(1,3,4,6)P4 (Echelon Bioscience, CAT#Q-1346) |
| Ins(1,4,5)P3 Beads (Echelon Bioscience, CAT#Q-B0145) |
| Ins(1,4,5)P3 Biotin (Echelon Bioscience, CAT#Q-145B) |
| IP3 Receptor Inhibitor 911 [Diphenyl (2,6-diaminohexanoate-O,N)-borane] (Echelon Bioscience, CAT#B-0370) |
| Isopentenyl Diphosphate (IPP) (Echelon Bioscience, CAT#I-0050) |
| Isopentenyl S-Thiolodiphosphate (ISPP) (Echelon Bioscience, CAT#I-S050) |
| IspF Inhibitor 1 (Echelon Bioscience, CAT#B-4102) |
| Juvenile Hormone III (racemic) (Echelon Bioscience, CAT#S-0155) |
| K118 (SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0344) |
| K149 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0345) |
| Kemptide (Phosphate Acceptor Peptide) (Echelon Bioscience, CAT#870-65) |
| Ki16425 (LPA Receptor Antagonist) (Echelon Bioscience, CAT#B-0730) |
| KISS (107-121) (Echelon Bioscience, CAT#548-19) |
| KISS (112-121) (Echelon Bioscience, CAT#548-17) |
| KISS-1 (125-144) (Echelon Bioscience, CAT#548-21) |
| KISS-1 (58-65) (Echelon Bioscience, CAT#548-11) |
| KISS-1 (68-80) (Echelon Bioscience, CAT#548-13) |
| KISS-1 (68-91) (Echelon Bioscience, CAT#548-14) |
| KISS-1 (94-121) (Echelon Bioscience, CAT#548-12) |
| KP372-1 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0102) |
| L-Ascorbyl-6-stearate (Echelon Bioscience, CAT#R-1218) |
| Lactosylceramide (LacCer) Beads (Echelon Bioscience, CAT#P-B0LC) |
| Laminin (929-933) (Echelon Bioscience, CAT#736-21) |
| Laminin A (2091-2108) (Echelon Bioscience, CAT#736-10) |
| LBPA Beads (Echelon Bioscience, CAT#P-BLBPA) |
| Leu-Enkephalin (Echelon Bioscience, CAT#310-75) |
| Leu-Enkephalin [D-Ala2] (Echelon Bioscience, CAT#310-84) |
| Leucokinin I (Echelon Bioscience, CAT#341-29) |
| Leumorphin (human) (Preproenkephalin B 226-254) (Echelon Bioscience, CAT#271-35) |
| LH-RH [D-Ala6] (Echelon Bioscience, CAT#550-44) |
| LH-RH [D-Lys6] (Echelon Bioscience, CAT#550-46) |
| LH-RH [D-Lys6] Free Acid (Echelon Bioscience, CAT#551-46) |
| LH-RH [D-Phe2,D-Ala6] (Echelon Bioscience, CAT#550-45) |
| LH-RH [Hyp9] (Echelon Bioscience, CAT#557-45) |
| LH-RH Free Acid (Echelon Bioscience, CAT#551-27) |
| LH-RH II alligator, chicken (Echelon Bioscience, CAT#558-39) |
| Linolenoyl LPA, 18:3 LPA (Echelon Bioscience, CAT#L-0183) |
| Linoleoyl LPA-d5, 18:2 LPA-d5 (Echelon Bioscience, CAT#L-0182d) |
| Linoleoyl LPA, 18:2 LPA (Echelon Bioscience, CAT#L-0182) |
| Locustapyrokinin [Glu6], Locusta Migratoria (Echelon Bioscience, CAT#361-26) |
| Locustapyrokinin, L. Migratoria (Echelon Bioscience, CAT#361-25) |
| LPA Beads (Echelon Bioscience, CAT#L-6101) |
| LPA Biotin (Echelon Bioscience, CAT#L-012B) |
| LPA ELISA Assay Service (Echelon Bioscience, CAT#T-2800S) |
| LPLA2 Activity Assay (Echelon Bioscience, CAT#K-7000A) |
| LPLA2 Inhibitor Screen (Echelon Bioscience, CAT#K-7000I) |
| LPS (16:0) (Echelon Bioscience, CAT#L-3216) |
| LY294002 (PI3-K Inhibitor) (Echelon Bioscience, CAT#B-0294) |
| Lysophosphatidic Acid Antibody (504B3) (Echelon Bioscience, CAT#Z-P200) |
| Lysophosphatidic Acid ELISA Kit (Echelon Bioscience, CAT#K-2800S) |
| LysoPI, 16:0 LPI (Echelon Bioscience, CAT#P-0160) |
| Malachite Green Assay Kit (Echelon Bioscience, CAT#K-1500) |
| Malachite Green Solution (Echelon Bioscience, CAT#K-1501) |
| Mast Cell Degranulating Peptide HR-1 (Echelon Bioscience, CAT#429-35) |
| Mast Cell Degranulating Peptide HR-2 (Echelon Bioscience, CAT#429-37) |
| Mastoparan, hornet Vespa basalis (Echelon Bioscience, CAT#887-20) |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate) (Echelon Bioscience, CAT#865-21) |
| Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate ) (Echelon Bioscience, CAT#866-10) |
| Melanotan II, cyclic α-MSH (Echelon Bioscience, CAT#571-56) |
| Melittin (Echelon Bioscience, CAT#920-32) |
| Membrane Lipid Arrays (Echelon Bioscience, CAT#P-6003) |
| Membrane Lipid Strips (Echelon Bioscience, CAT#P-6002) |
| MeOSuc-Ala-Ala-Pro-Val-4MbNA (Pancreatic Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-19) |
| MeOSuc-Ala-Ala-Pro-Val-AFC Pancreatic Leukocyte Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-17) |
| MEP Synthase (DXR) Enzyme Inhibitor Screen (Echelon Bioscience, CAT#K-2000C) |
| MEP Synthase (DXR), active (Echelon Bioscience, CAT#E-2000C) |
| Mesobiliverdin (microbial sourced) (Echelon Bioscience, CAT#F-H160) |
| Met Enkephalin [Lys 6] (Echelon Bioscience, CAT#310-59) |
| Metastin, KISS -1 (68-121) (Echelon Bioscience, CAT#548-25) |
| Methoxysuccinyl-Ala-Ala-Arg-pNA (Echelon Bioscience, CAT#876-07) |
| Methoxysuccinyl-Pro-Ser-Pro-Phe-AMC (Echelon Bioscience, CAT#877-02) |
| Methyl glucoside sesquistearate (Echelon Bioscience, CAT#R-1018) |
| MG-115 (Proteasome Inhibitor) (Echelon Bioscience, CAT#882-10) |
| MG-132 Proteasome Inhibitor (Echelon Bioscience, CAT#882-11) |
| Miltefosine (Echelon Bioscience, CAT#L-1216) |
| Mini Gastrin I, human (Echelon Bioscience, CAT#471-11) |
| MMP 13 Substrate, fluorogenic (Echelon Bioscience, CAT#868-30) |
| MMP 14 substrate Stomelysine-3, fluorogenic (Echelon Bioscience, CAT#868-42) |
| MMP 2 Substrate, fluorogenic (Echelon Bioscience, CAT#868-20) |
| MMP Inhibitor I (Echelon Bioscience, CAT#868-75) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-22) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-41) |
| MMP-3 Inhibitor 1 (Echelon Bioscience, CAT#868-60) |
| MMP-3 Substrate, fluorogenic (Echelon Bioscience, CAT#868-62) |
| MMV008138(1R,3S) (IspD Inhibitor) (Echelon Bioscience, CAT#B-4103) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, human (Echelon Bioscience, CAT#651-10) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, rat (Echelon Bioscience, CAT#645-10) |
| MOG Protein (68-84), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, guinea pig (Echelon Bioscience, CAT#920-63) |
| Monobromobimane (Echelon Bioscience, CAT#F-0030) |
| Monocaprin (Echelon Bioscience, CAT#L-9010) |
| Monolaurin (Echelon Bioscience, CAT#L-9012) |
| Monomyristin (Echelon Bioscience, CAT#L-9014) |
| MOPC (17:0/18:1 PC) (Echelon Bioscience, CAT#L-1117) |
| MOPEth (17:0/18:1 PEth) (Echelon Bioscience, CAT#L-6017) |
| Morphine Modulating Neuropeptide (Echelon Bioscience, CAT#340-79) |
| Motilin, dog (Echelon Bioscience, CAT#496-25) |
| Motilin, human (Echelon Bioscience, CAT#491-15) |
| ms-PtdIns(4,5)P2 diC16 (Echelon Bioscience, CAT#P-F4516) |
| ms-PtdIns(4,5)P2 diC8 (Echelon Bioscience, CAT#P-F4508) |
| MultiPIP Grip (Echelon Bioscience, CAT#G-9901) |
| Myelin Proteolipid Protein (139-151) [Ser 140] (depalmitoylated), h, b, d, m, r (Echelon Bioscience, CAT#720-10) |
| Myosin Light Chain Kinase (11-19) amide (Echelon Bioscience, CAT#892-96) |
| Myosin Light Chain Kinase Substrate (Smooth muscle) (Echelon Bioscience, CAT#930-30) |
| MZ-4-169 (Echelon Bioscience, CAT#531-92) |
| MZ-4-181 (Echelon Bioscience, CAT#531-93) |
| MZ-4-71 (Echelon Bioscience, CAT#531-91) |
| N-Acetyl Beta Endorphin, human (Echelon Bioscience, CAT#291-29) |
| N-arachidonoyl-DPPE (NAPE 20:4) (Echelon Bioscience, CAT#L-2404) |
| N-Biotin Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500B) |
| N-Linoleoyl-DPPE (Echelon Bioscience, CAT#L-2420) |
| N-NBD Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500N6) |
| N-Oleoyl-DPPE (Echelon Bioscience, CAT#L-2419) |
| N-palmitoyl-DPPE (NAPE 16:0) (Echelon Bioscience, CAT#L-2416) |
| N-Stearoyl Ceramide 1-phosphate (Echelon Bioscience, CAT#S-5018) |
| N-Stearoyl-DPPE (Echelon Bioscience, CAT#L-2418) |
| nanoHA-5 (Echelon Bioscience, CAT#HYA-NANO5-1) |
| NBD-Phosphatidylethanol (Echelon Bioscience, CAT#L-60N16) |
| NeoBeads – PIP Purification System (Echelon Bioscience, CAT#P-B999) |
| Neryl Diphosphate (NPP) (Echelon Bioscience, CAT#I-0120) |
| Neurokinin A [Tyr5,DTrp6,8,9Lys10] (4-10) (Echelon Bioscience, CAT#631-70) |
| Neurokinin A [Ala5, BetaAla8],(4-10) (Echelon Bioscience, CAT#631-65) |
| Neuromedin B (Echelon Bioscience, CAT#630-62) |
| Neuromedin N (Echelon Bioscience, CAT#634-46) |
| Neuromedin U-8 (Echelon Bioscience, CAT#630-65) |
| Neuropeptide Y (3-36), human, rat / NPY (3-36) (Echelon Bioscience, CAT#614-41) |
| Neuropeptide Y (3-36), porcine / NPY (3-36) (Echelon Bioscience, CAT#614-39) |
| Neuropeptide Y (human, rat) (Echelon Bioscience, CAT#611-26) |
| Neuropeptide Y, porcine / NPY, porcine (Echelon Bioscience, CAT#614-30) |
| Neurotensin [D-Trp11] (Echelon Bioscience, CAT#631-38) |
| Neurotensin, human (Echelon Bioscience, CAT#631-27) |
| Neutral Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-1800) |
| Neutral Sphingomyelinase Assay Service (Echelon Bioscience, CAT#T-1800) |
| NFF 2 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-25) |
| NFF 3 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-10) |
| Nociceptin/Orphanin FQ (Echelon Bioscience, CAT#310-78) |
| NOG (N-oxalylglycine) (Echelon Bioscience, CAT#F-0020) |
| Non-A-Beta Component Amyloid (Echelon Bioscience, CAT#641-80) |
| Nonfluorescent Carrier Pack (Echelon Bioscience, CAT#P-9C00) |
| NVP-231 (Ceramide Kinase Inhibitor) (Echelon Bioscience, CAT#B-0040) |
| Obestatin (11-23), mouse (Echelon Bioscience, CAT#475-96) |
| Obestatin, human (Echelon Bioscience, CAT#471-97) |
| Obestatin, mouse (Echelon Bioscience, CAT#475-97) |
| Octreotide (Echelon Bioscience, CAT#690-44) |
| Oleoyl 3-carbacyclic Phosphatidic Acid (Echelon Bioscience, CAT#L-7218) |
| Oleoyl LPA, 18:1 LPA (Echelon Bioscience, CAT#L-0181) |
| Oral Formulation Vehicle (Echelon Bioscience, CAT#B-0706) |
| Orexin A (human, rat, mouse) (Echelon Bioscience, CAT#471-99) |
| Orexin A, Xenopus SS (4-10/5-12) (Echelon Bioscience, CAT#479-99) |
| Orexin B, human (Echelon Bioscience, CAT#471-98) |
| Oxyntomodulin (Glucagon 1-37) (Echelon Bioscience, CAT#471-33) |
| Oxytocin (Echelon Bioscience, CAT#670-67) |
| p-I-L-Phe4 human beta amyloid (1-40) (Echelon Bioscience, CAT#640-33) |
| P-lysoPC (16:0 LPC) (Echelon Bioscience, CAT#L-1516) |
| PACAP (1-27), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-37) |
| PACAP (1-38), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-35) |
| Palmitoyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0310) |
| Pancreastatin (1-52), human (Echelon Bioscience, CAT#481-20) |
| Pancreatic Elastase Substrate, colorimetric (Echelon Bioscience, CAT#883-18) |
| Pancreatic Leukocyte Elastase Substrate, colorimetric (Echelon Bioscience, CAT#881-15) |
| Pancreatic polypeptide bovine (Echelon Bioscience, CAT#474-21) |
| Pancreatic Polypeptide, avian (Echelon Bioscience, CAT#478-40) |
| PAPEth (16:0/20:4 PEth) (Echelon Bioscience, CAT#L-6024) |
| PAR (1-6) amide [Ala1], Mouse (Echelon Bioscience, CAT#875-28) |
| PAR-1 agonist (Echelon Bioscience, CAT#875-27) |
| PAR-2 (1-6)amide human (Echelon Bioscience, CAT#875-23) |
| Parathyroid Hormone (PTH) (1-34), human (Echelon Bioscience, CAT#231-40) |
| Parathyroid Hormone (PTH) (1-34), rat (Echelon Bioscience, CAT#235-36) |
| Parathyroid Hormone (PTH) (2-34), human (Echelon Bioscience, CAT#231-43) |
| Parathyroid Hormone (PTH) (3-34), human (Echelon Bioscience, CAT#231-46) |
| Parathyroid Hormone (PTH) (39-68), human (Echelon Bioscience, CAT#231-50) |
| Parathyroid Hormone (PTH) (39-84), human (Echelon Bioscience, CAT#231-55) |
| Parathyroid Hormone (PTH) (4-34), human (Echelon Bioscience, CAT#231-48) |
| Parathyroid Hormone (PTH) (5-34), human (Echelon Bioscience, CAT#231-51) |
| Parathyroid Hormone (PTH) (53-84), human (Echelon Bioscience, CAT#231-60) |
| Parathyroid Hormone (PTH) [Nle8,18,Tyr34] (3-34), amide, bovine (Echelon Bioscience, CAT#233-35) |
| Parathyroid Hormone [Nle8,18,Tyr34](1-34) amide, bovine (Echelon Bioscience, CAT#233-32) |
| PC Lipid Microparticles (Echelon Bioscience, CAT#P-B1PC) |
| PC/PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PCPS) |
| PDQ, Antimicrobial Peptide from Xenopus Laevis (Echelon Bioscience, CAT#745-10) |
| Peptide YY, PYY (3-36) , canine , mouse , porcine , rat (Echelon Bioscience, CAT#490-56) |
| Peptide YY, PYY (3-36), human (Echelon Bioscience, CAT#490-11) |
| PF-543 (Sphingosine Kinase I Inhibitor) (Echelon Bioscience, CAT#B-0026) |
| PF-8380 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0702) |
| Phe-Met-Arg-D-Phe-NH2 (Echelon Bioscience, CAT#610-49) |
| Phe-Met-Arg-Phe-NH2 (FMRF Peptide) (Echelon Bioscience, CAT#610-44) |
| Pheromonotropin, Pseudalatia (Echelon Bioscience, CAT#782-10) |
| PHI, rat (Echelon Bioscience, CAT#495-25) |
| Phosphatase Substrate (Echelon Bioscience, CAT#871-70) |
| Phosphatidic Acid (PA) Beads (Echelon Bioscience, CAT#P-B0PA) |
| Phosphatidylcholine (PC) Beads (Echelon Bioscience, CAT#P-B0PC) |
| Phosphatidylethanol (PEth) Beads (Echelon Bioscience, CAT#P-BPETH) |
| Phosphatidylethanol (PEth) ELISA (Echelon Bioscience, CAT#K-5000) |
| Phosphatidylethanolamine (PE) Beads (Echelon Bioscience, CAT#P-B0PE) |
| Phosphatidylinositol 4,5-bisphosphate 18:0/20:4 (Echelon Bioscience, CAT#P-4524) |
| Phosphatidylinositol diC16 (PI diC16) (Echelon Bioscience, CAT#P-0016) |
| Phosphatidylinositol diC4 (PI diC4) (Echelon Bioscience, CAT#P-0004) |
| Phosphatidylinositol diC8 (ammonium salt) (Echelon Bioscience, CAT#P-0008A) |
| Phosphatidylinositol diC8 (PI diC8) (Echelon Bioscience, CAT#P-0008) |
| Phosphatidylserine (PS) Beads (Echelon Bioscience, CAT#P-B0PS) |
| Phospholipase A2 activating peptide (Echelon Bioscience, CAT#495-26) |
| PI PolyPIPosomes (Echelon Bioscience, CAT#Y-P000) |
| PI-103 (PI3-K alpha Inhibitor 1) (Echelon Bioscience, CAT#B-0303) |
| PI(3,4,5)P3 17:0/16:0 (Echelon Bioscience, CAT#P-3917) |
| PI(3,4,5)P3 18:0/20:4 (Echelon Bioscience, CAT#P-3924) |
| PI(3,4,5)P3 diC16 (Echelon Bioscience, CAT#P-3916) |
| PI(3,4,5)P3 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3916A) |
| PI(3,4,5)P3 diC4 (Echelon Bioscience, CAT#P-3904) |
| PI(3,4,5)P3 diC8 (Echelon Bioscience, CAT#P-3908) |
| PI(3,4,5)P3 Grip (Grp1-PH) (Echelon Bioscience, CAT#G-3901) |
| PI(3,4,5)P3 PIP Beads (Echelon Bioscience, CAT#P-B345A) |
| PI(3,4,5)P3 PolyPIPosomes (Echelon Bioscience, CAT#Y-P039) |
| PI(3,4)P2 diC16 (Echelon Bioscience, CAT#P-3416) |
| PI(3,4)P2 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3416A) |
| PI(3,4)P2 diC4 (Echelon Bioscience, CAT#P-3404) |
| PI(3,4)P2 diC8 (Echelon Bioscience, CAT#P-3408) |
| PI(3,4)P2 Mass ELISA (Echelon Bioscience, CAT#K-3800) |
| PI(3,4)P2 PIP Beads (Echelon Bioscience, CAT#P-B034A) |
| PI(3,4)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P034) |
| PI(3,5)P2 diC16 (Echelon Bioscience, CAT#P-3516) |
| PI(3,5)P2 diC4 (Echelon Bioscience, CAT#P-3504) |
| PI(3,5)P2 diC8 (Echelon Bioscience, CAT#P-3508) |
| PI(3,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B035A) |
| PI(3,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P035) |
| PI(3)P diC16 (Echelon Bioscience, CAT#P-3016) |
| PI(3)P diC4 (Echelon Bioscience, CAT#P-3004) |
| PI(3)P diC8 (Echelon Bioscience, CAT#P-3008) |
| PI(3)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-3008A) |
| PI(3)P Grip (p40 PX) (Echelon Bioscience, CAT#G-0302) |
| PI(3)P Mass ELISA (Echelon Bioscience, CAT#K-3300) |
| PI(3)P PIP Beads (Echelon Bioscience, CAT#P-B003A) |
| PI(3)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P003) |
| PI(4,5)P2 diC16 (Echelon Bioscience, CAT#P-4516) |
| PI(4,5)P2 diC4 (Echelon Bioscience, CAT#P-4504) |
| PI(4,5)P2 diC8 (Echelon Bioscience, CAT#P-4508) |
| PI(4,5)P2 Grip (PLC-d1-PH) (Echelon Bioscience, CAT#G-4501) |
| PI(4,5)P2 Mass ELISA Kit (Echelon Bioscience, CAT#K-4500) |
| PI(4,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B045A) |
| PI(4,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P045) |
| PI(4)P 5-Kinase (PIP5KI) Activity Assay (Echelon Bioscience, CAT#K-5700) |
| PI(4)P diC16 (Echelon Bioscience, CAT#P-4016) |
| PI(4)P diC4 (Echelon Bioscience, CAT#P-4004) |
| PI(4)P diC8 (Echelon Bioscience, CAT#P-4008) |
| PI(4)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-4008A) |
| PI(4)P Grip (SidC-3C) (Echelon Bioscience, CAT#G-0402) |
| PI(4)P Mass ELISA Kit (Echelon Bioscience, CAT#K-4000E) |
| PI(4)P PIP Beads (Echelon Bioscience, CAT#P-B004A) |
| PI(4)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P004) |
| PI(5)P 4-Kinase (PIP4KII) Activity Assay (Echelon Bioscience, CAT#K-5400) |
| PI(5)P diC16 (Echelon Bioscience, CAT#P-5016) |
| PI(5)P diC4 (Echelon Bioscience, CAT#P-5004) |
| PI(5)P diC8 (Echelon Bioscience, CAT#P-5008) |
| PI(5)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-5008A) |
| PI(5)P PIP Beads (Echelon Bioscience, CAT#P-B005A) |
| PI(5)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P005) |
| PI3-K alpha Inhibitor 2 (Echelon Bioscience, CAT#B-0304) |
| PI3-K Alpha Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300A) |
| PI3-K Beta Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300B) |
| PI3-Kinase Activity AlphaScreen Assay (Echelon Bioscience, CAT#K-1300) |
| PI3-Kinase Activity ELISA: Pico (Echelon Bioscience, CAT#K-1000S) |
| PI3-Kinase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1100) |
| PI3-Kinase alpha (PI3Ka), active (Echelon Bioscience, CAT#E-2000) |
| PI3K (p110alpha/p85alpha), active (Echelon Bioscience, CAT#P27-18H) |
| PI3K (p110beta/p85alpha), active (Echelon Bioscience, CAT#P28-102H) |
| PI3Ka, E545K – Active Mutant (Echelon Bioscience, CAT#P27-15H) |
| PI4-Kinase Activity Assay (Echelon Bioscience, CAT#K-4000K) |
| PI4-Kinase beta (PI4Kb), active (Echelon Bioscience, CAT#P32-102G) |
| PI4-Kinase II alpha (PI4KIIa), active (Echelon Bioscience, CAT#P21-10G) |
| PI4-Kinase II beta (PI4KIIb), active (Echelon Bioscience, CAT#P22-10G) |
| PIK-93 (PI4KIIIb inhibitor) (Echelon Bioscience, CAT#B-0306) |
| PIP Array – Lipid-Protein Interaction Assay (Echelon Bioscience, CAT#P-6100) |
| PIP Beads Sample Pack (Echelon Bioscience, CAT#P-B00S) |
| PIP Pack (Echelon Bioscience, CAT#P-P100) |
| PIP Strips (Echelon Bioscience, CAT#P-6001) |
| PIP3 Mass ELISA Kit (Echelon Bioscience, CAT#K-2500S) |
| PKA Inhibitor (Echelon Bioscience, CAT#867-10) |
| PKA Substrate (Echelon Bioscience, CAT#866-25) |
| PKC Isoenzyme Inhibitor (myristoylated) (Echelon Bioscience, CAT#880-17) |
| PKC Isoenzyme Inhibitor / PKC Y translocation peptide (Echelon Bioscience, CAT#880-15) |
| PKC(e) Translocation Inhibitor – negative control (Echelon Bioscience, CAT#880-69) |
| PKG Substrate, Glasstide, H2Btide (Echelon Bioscience, CAT#870-74) |
| PKI (5-24), PKA Inhbibitor (Echelon Bioscience, CAT#890-98) |
| Plasmepsin II substrate (Echelon Bioscience, CAT#871-13) |
| PLPC (16:0/12:0 PC) (Echelon Bioscience, CAT#L-1612) |
| PLPC (16:0/18:2 PC) (Echelon Bioscience, CAT#L-1122) |
| PLPEth (16:0/18:2 PEth) (Echelon Bioscience, CAT#L-6020) |
| Pneumadin, rat (Echelon Bioscience, CAT#675-85) |
| PNPP Substrate & Solution (Echelon Bioscience, CAT#K-1208T) |
| Poly-Selective Phosphoinositide Phosphate Antibody (Echelon Bioscience, CAT#Z-P999) |
| POPC (16:0/18:1 PC) (Echelon Bioscience, CAT#L-1618) |
| POPEth (16:0/18:1 PEth) (Echelon Bioscience, CAT#L-6019) |
| Porphobilinogen (Echelon Bioscience, CAT#F-H020) |
| PPlases Substare, fluorogenic (Echelon Bioscience, CAT#869-20) |
| PPLases Substrate, colorimetric (Echelon Bioscience, CAT#869-10) |
| ProAM N20, human / Proadrenomedullin N-term 20 Peptide, huma (Echelon Bioscience, CAT#331-81) |
| ProAM N20, rat / Proadrenomedullin N terminal 20 peptide, rat (Echelon Bioscience, CAT#335-81) |
| Prodynorphin 228-256 (porcine) (Dynorphin B 29, Leumorphin) (Echelon Bioscience, CAT#274-56) |
| Propargyl-farnesol (Echelon Bioscience, CAT#S-0160) |
| Propargyl-geraniol (Echelon Bioscience, CAT#S-0110) |
| Prostate Specific Antigen Substrate (Echelon Bioscience, CAT#891-15) |
| Prot. Kin. C Pseudosubstrate Inhibitor (Echelon Bioscience, CAT#890-91) |
| Protein Kinase C (19-31), Protein Kinase C pseudosubstrate, (Echelon Bioscience, CAT#871-20) |
| Protein Kinase C Substrate (Echelon Bioscience, CAT#890-82) |
| Protein Kinase C substrate from EGF Receptor (Echelon Bioscience, CAT#871-55) |
| Protein Kinase Inhibitor Cdk2 (Echelon Bioscience, CAT#871-87) |
| Protein Tyrosine Phosphatase Substrate, fluorogenic (Echelon Bioscience, CAT#871-62) |
| Protoporphyrin IX (Echelon Bioscience, CAT#F-H050) |
| PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PS) |
| PS48 (PDK1 Activator) (Echelon Bioscience, CAT#B-0360) |
| PtdIns PIP Beads (Echelon Bioscience, CAT#P-B001) |
| PtdIns(4,5)P2 a-fluorovinylphosphate diC8 (Echelon Bioscience, CAT#P-FV4508) |
| PTEN Activity ELISA Kit (Echelon Bioscience, CAT#K-4700) |
| PTEN Enzyme, active (Echelon Bioscience, CAT#E-3000) |
| PTH Related Peptide (7-34) amide, human (Echelon Bioscience, CAT#231-94) |
| PTH Related Peptide [Asn10,Leu11] (7-34) amide, human (Echelon Bioscience, CAT#231-95) |
| PTH Related Peptide [Leu11, DTrp12] (7-34) amide, human (Echelon Bioscience, CAT#231-96) |
| PTH Related protein (1-40); Hypercalcemia Malignancy Factor (Echelon Bioscience, CAT#231-85) |
| Purified Anti-LPLA2 Antibody (Echelon Bioscience, CAT#Z-PLPLA2) |
| Purified Anti-Phosphatidylethanol Antibody (Echelon Bioscience, CAT#Z-PETH) |
| Purified Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-P345B) |
| Purified Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-P345) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034B) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034) |
| Purified Anti-PtdIns(3,5)P2 IgG (Echelon Bioscience, CAT#Z-P035) |
| Purified Anti-PtdIns(3)P IgG (Echelon Bioscience, CAT#Z-P003) |
| Purified Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-P045) |
| Purified Anti-PtdIns(4)P IgM (Echelon Bioscience, CAT#Z-P004) |
| Purified Mouse Anti-LBPA (BMP) (Echelon Bioscience, CAT#Z-PLBPA) |
| Rabbit Anti-Human DGK Zeta Antibody (Echelon Bioscience, CAT#Z-DGKZ) |
| Ranakinin, frog (Echelon Bioscience, CAT#361-50) |
| Renin Substrate I (Echelon Bioscience, CAT#131-20) |
| Resveratrol (Echelon Bioscience, CAT#B-0021) |
| Rha(rac)C10C10 (Echelon Bioscience, CAT#RL10105) |
| Rha(rac)C12C12 (Echelon Bioscience, CAT#RL12125) |
| RR-SRC, Insulin receptor kinase substrate (Echelon Bioscience, CAT#870-68) |
| S-lysoPC, (18:0 LPC) (Echelon Bioscience, CAT#L-1518) |
| S1P Beads (Echelon Bioscience, CAT#S-6110) |
| S1P Fluorescein (Echelon Bioscience, CAT#S-200F) |
| S1P Lyase Fluorogenic Substrate (Echelon Bioscience, CAT#S-200U) |
| S1P TAMRA (Echelon Bioscience, CAT#S-200T) |
| S32826 [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt] (Echelon Bioscience, CAT#L-3282) |
| S6 Phosphate Acceptor Peptide (Echelon Bioscience, CAT#890-72) |
| Sarafotoxin 6b (Echelon Bioscience, CAT#339-10) |
| Sarilesin – Angiotensin II [Sar1,Ile8] (Echelon Bioscience, CAT#131-63) |
| Sauvagine, frog (Echelon Bioscience, CAT#357-26) |
| SDT1 (Pyrimidine 5′-nucleotidase) (Echelon Bioscience, CAT#E-20SDT1) |
| Select-HA 1000k (Echelon Bioscience, CAT#HYA-1000KEF-1) |
| Select-HA 500k (Echelon Bioscience, CAT#HYA-500KEF-1) |
| Select-HA 50k (Echelon Bioscience, CAT#HYA-50KEF-1) |
| Select-HA 601k (Echelon Bioscience, CAT#HYA-601KEF-1) |
| Select-HA HiLadder (Echelon Bioscience, CAT#HYA-HILAD-20) |
| Select-HA LoLadder (Echelon Bioscience, CAT#HYA-LOLAD-20) |
| Senktide ;Substance P [Suc-,Asp6,Me-Phe8] (6-11) (Echelon Bioscience, CAT#712-14) |
| SF1670 (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0350) |
| Sheep Anti-Human DGK Alpha Peptide Antibody (Echelon Bioscience, CAT#Z-DGKA) |
| SHIP2 Lipid Phosphatase Enzyme, active (Echelon Bioscience, CAT#E-1000) |
| SHIP2 Reaction Buffer (Echelon Bioscience, CAT#K-S2RB) |
| Shuttle PIP Kit, PtdIns(3,4,5)P3 (Echelon Bioscience, CAT#P-9039) |
| Shuttle PIP Kit, PtdIns(3,4)P2 (Echelon Bioscience, CAT#P-9034) |
| Shuttle PIP Kit, PtdIns(3,5)P2 (Echelon Bioscience, CAT#P-9035) |
| Shuttle PIP Kit, PtdIns(3)P (Echelon Bioscience, CAT#P-9003) |
| Shuttle PIP Kit, PtdIns(4,5)P2 (Echelon Bioscience, CAT#P-9045) |
| Shuttle PIP Kit, PtdIns(4)P (Echelon Bioscience, CAT#P-9004) |
| Shuttle PIP Kit, PtdIns(5)P (Echelon Bioscience, CAT#P-9005) |
| SKI-178 (SPHK1 Inhibitor) (Echelon Bioscience, CAT#B-0028) |
| SLPEth (18:0/18:2 PEth) (Echelon Bioscience, CAT#L-6022) |
| SMPC (18:0/14:0 PC) (Echelon Bioscience, CAT#L-1814) |
| sn-1-Fluorescein-labeled Cardiolipin (Echelon Bioscience, CAT#L-C16F) |
| Sn(IV) Protoporphyrin IX, 14325-05-4 (Echelon Bioscience, CAT#F-H080) |
| SNP-1 (Echelon Bioscience, CAT#888-10) |
| Somatostatin 28 (1-12) (Echelon Bioscience, CAT#691-77) |
| Somatostatin 28, cyclic (Echelon Bioscience, CAT#691-65) |
| Somatostatin Antagonist, cyclic / Coy (Echelon Bioscience, CAT#691-63) |
| Somatostatin, cyclic (Echelon Bioscience, CAT#691-25) |
| SOPEth (18:0/18:1 PEth) (Echelon Bioscience, CAT#L-6021) |
| Sorbitan monostearate (Echelon Bioscience, CAT#R-1318) |
| Spantide ([D-Arg1,D-Trp7,9,Substance P Leu11] (Echelon Bioscience, CAT#712-31) |
| Spantide II (Echelon Bioscience, CAT#712-36) |
| Specific NFAT Inhibitor / VIVIT-16 (Echelon Bioscience, CAT#887-16) |
| Sperm Activating Peptide, Sea Urchin (Echelon Bioscience, CAT#610-52) |
| Sphinganine-biotin (Echelon Bioscience, CAT#S-110B) |
| Sphinganine-fluorescein (Echelon Bioscience, CAT#S-110F) |
| Sphingo Arrays (Echelon Bioscience, CAT#S-6001) |
| Sphingo Beads (Echelon Bioscience, CAT#S-6100) |
| Sphingo Beads Sample Pack (Echelon Bioscience, CAT#P-B00SS) |
| Sphingo Strips (Echelon Bioscience, CAT#S-6000) |
| Sphingomyelin Beads (Echelon Bioscience, CAT#P-B0SM) |
| Sphingosine 1-Phosphate (S1P) (Echelon Bioscience, CAT#S-2000) |
| Sphingosine 1-Phosphate Antibody (Echelon Bioscience, CAT#Z-P300) |
| Sphingosine 1-Phosphate Assay Service (Echelon Bioscience, CAT#T-1900) |
| Sphingosine 1-phosphate biotin (S1P-biotin) (Echelon Bioscience, CAT#S-200B) |
| Sphingosine 1-Phosphate ELISA Kit (Echelon Bioscience, CAT#K-1900) |
| Sphingosine 1-Phosphate Lyase Overexpression Lysate, active (Echelon Bioscience, CAT#E-5000L) |
| Sphingosine 1-Phosphate Lyase, active (Echelon Bioscience, CAT#E-5000P) |
| Sphingosine kinase 1, active (Echelon Bioscience, CAT#E-K068) |
| Sphingosine kinase 2, active (Echelon Bioscience, CAT#E-K069) |
| Sphingosine Kinase Activity Assay (Echelon Bioscience, CAT#K-3500) |
| Sphingosine Kinase Inhibitor (SKI-II) (Echelon Bioscience, CAT#B-0024) |
| Sphingosine-biotin (Echelon Bioscience, CAT#S-100B) |
| Sphingosine-fluorescein (Echelon Bioscience, CAT#S-100F) |
| Sphingosine-tetramethylrhodamine (Echelon Bioscience, CAT#S-100T) |
| Squalene, purified (Echelon Bioscience, CAT#S-0300) |
| SS14 Tumor Inhibitor Analog (Echelon Bioscience, CAT#691-60) |
| Stercobilin Hydrochloride (Echelon Bioscience, CAT#F-H150) |
| Substance P (Echelon Bioscience, CAT#711-25) |
| Substance P (5-11) / Hepta-Substance P (Echelon Bioscience, CAT#711-66) |
| Substance P [Nle11] (Echelon Bioscience, CAT#711-36) |
| Substance P [Sar9] (Echelon Bioscience, CAT#711-48) |
| Substance P [Tyr8] (Echelon Bioscience, CAT#711-33) |
| Substance P, (p-Cl-Phe7,8) (Echelon Bioscience, CAT#712-55) |
| Substrate for E. Coli Leader Peptidase (Echelon Bioscience, CAT#887-10) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-77) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-78) |
| Suc-Ala-Ala-Ala-Ala-pNA (Echelon Bioscience, CAT#876-02) |
| Suc-Ala-Ala-Leu-pNA (Echelon Bioscience, CAT#876-03) |
| Suc-Ala-Ala-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-32) |
| Suc-Ala-Ala-Pro-Phe-AFC (Pancreatic Elastase Substrate (human), fluorogenic) (Echelon Bioscience, CAT#881-34) |
| Suc-Ala-Ala-Pro-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-31) |
| Suc-Ala-Ala-Pro-Phe-pNA (Pancreatic Leukocyte Elastase (human) Substrate, colorimetric) (Echelon Bioscience, CAT#881-30) |
| Suc-Gly-Gly-Phe-pNA (Chymotrypsin Substrate , colorimetric) (Echelon Bioscience, CAT#881-33) |
| Suc-Leu-Leu-Val-Tyr-AFC (Chymotrypsin like Enzyme Substrate, fluorogenic) (Echelon Bioscience, CAT#881-21) |
| Suc-Leu-Leu-Val-Tyr-AMC (Proteosome Substrate) (Echelon Bioscience, CAT#881-18) |
| Suc-Leu-Tyr-4-methoxy-2-naphthylamide (Calpain I & II, Papain Substrate, fluorogenic) (Echelon Bioscience, CAT#878-01) |
| Suc-Phe-Ala-His-Phe-AMC (Echelon Bioscience, CAT#877-10) |
| Suc-Phe-Ala-His-Phe-pNA (Echelon Bioscience, CAT#876-04) |
| Synthetic 16:0 Cardiolipin (Echelon Bioscience, CAT#L-C160) |
| Synthetic 16:0 Monolysocardiolipin (Echelon Bioscience, CAT#L-M160) |
| Syntide 2, CaMKII Substrate (Echelon Bioscience, CAT#105-77) |
| TACE Substrate (Fluorogenic) (Echelon Bioscience, CAT#860-78) |
| Thio-ccPA (Echelon Bioscience, CAT#L-7118) |
| Thrombin , Trypsin , Papain Substrate (Echelon Bioscience, CAT#920-13) |
| Thrombin Receptor Activator Peptide 6 / TRAP-6 (Echelon Bioscience, CAT#920-51) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-29) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-53) |
| Thrombin Receptor Agonist; (Echelon Bioscience, CAT#920-52) |
| Thrombin Receptor Antagonist (Echelon Bioscience, CAT#920-50) |
| Thymosin b4 (1-4) (Echelon Bioscience, CAT#885-21) |
| TMB Precipitating (Echelon Bioscience, CAT#K-TMBP) |
| TMR Labeled Carrier 1 (Neomycin B Sulfate) (Echelon Bioscience, CAT#P-9C1R) |
| TMR Labeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2R) |
| TNF coverting enzyme substrate (Echelon Bioscience, CAT#882-50) |
| Trismethoxyresveratrol (Echelon Bioscience, CAT#B-0022) |
| Tyr(PO3H2)4 Angiotensin II, human (Echelon Bioscience, CAT#131-48) |
| Tyrosine Specific Protein Kinase Inhibitor Peptide A (Echelon Bioscience, CAT#890-88) |
| Unlabeled Shuttle PIP Carrier 1 (Echelon Bioscience, CAT#P-9C1) |
| Unlabeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2) |
| Unlabeled Shuttle PIP Carrier 3 (Echelon Bioscience, CAT#P-9C3) |
| Uridine Diphosphate-Bodipy-FL (UDP-Bodipy-FL) (Echelon Bioscience, CAT#N-100F) |
| Urobilin Hydrochloride (Echelon Bioscience, CAT#F-H140) |
| Urocortin, human (Echelon Bioscience, CAT#353-10) |
| Urocortin, rat (Echelon Bioscience, CAT#353-20) |
| Urodilatin (Echelon Bioscience, CAT#151-30) |
| Uroporphyrin I dihydrochloride (Echelon Bioscience, CAT#F-H040) |
| Uroporphyrin III dihydrochloride (Echelon Bioscience, CAT#F-H030) |
| Urotensin I, carp (Echelon Bioscience, CAT#817-40) |
| Urotensin I, suckerfish (Echelon Bioscience, CAT#817-30) |
| Urotensin II, human (Echelon Bioscience, CAT#817-50) |
| Vasoactiv Intestinal Peptide [Lys1,Pro2,5,Arg3,4,Tyr6] / VI (Echelon Bioscience, CAT#491-32) |
| Vasoactive Intestinal Constrictor / Mouse Beta Endothelin / (Echelon Bioscience, CAT#337-10) |
| Vasoactive Intestinal Peptide (6-28),human, porcine, rat / V (Echelon Bioscience, CAT#491-29) |
| Vasoactive Intestinal Peptide / VIP, human, porcine, rat (Echelon Bioscience, CAT#491-25) |
| Vasopressin ( Pmp1,Tyr(Et)2,Val4,Arg8 ) cyclic (Echelon Bioscience, CAT#670-32) |
| Vasopressin [Arg8] (AVP), cyclic (Echelon Bioscience, CAT#670-18) |
| Vasopressin [Deamino-Pen1,Val4,D-Arg8] (Echelon Bioscience, CAT#670-36) |
| Vasopressin [Lys-8] (Echelon Bioscience, CAT#670-17) |
| Vasopressin [Pmp1, Tyr(0Me)2, Arg8] (Echelon Bioscience, CAT#670-24) |
| Vasotocin [Arg8] cyclic (Echelon Bioscience, CAT#670-65) |
| Versican G1 Domain (Echelon Bioscience, CAT#G-HA01) |
| VIP Antagonist [Ac-Tyr1,D-Phe2]-GRF(1-29)NH2 (Echelon Bioscience, CAT#491-41) |
| VO-OHpic (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0351) |
| VPC 23019 (S1P1/3 Antagonist) (Echelon Bioscience, CAT#B-0061) |
| Whole-Cell MEP Pathway-Selective Antibacterial Screening Assay Service (Echelon Bioscience, CAT#T-2000) |
| Wortmannin (Echelon Bioscience, CAT#B-0222) |
| XY-14 (Lipid Phosphate Phosphatase 1 Inhibitor) (Echelon Bioscience, CAT#L-9218) |
| XY-17 (LPA3 Agonist) (Echelon Bioscience, CAT#L-9118) |
| XY-4 (LPA analog) (Echelon Bioscience, CAT#L-1160) |
| Z-Ala-Ala-Asp-AFC (Cathepsin S Substrate, fluorogenic) (Echelon Bioscience, CAT#874-06) |
| Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II, fluorogenic) (Echelon Bioscience, CAT#866-29) |
| Z-Ala-Lys-Arg-AMC (Echelon Bioscience, CAT#877-03) |
| Z-Arg-Arg-AMC (Cathepsin B substrate, fluorogenic) (Echelon Bioscience, CAT#866-30) |
| Z-Arg-Arg-MbNA (Cathepsin B Substrate, fluorogenic) (Echelon Bioscience, CAT#866-31) |
| Z-Arg-Arg-pNA (Cathepsin B substrate, colorimetric) (Echelon Bioscience, CAT#866-27) |
| Z-Asp-Glu-Val-Asp-AFC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-18) |
| Z-Asp-Glu-Val-Asp-pNA (Caspase 3 (Apopain) substrate) (Echelon Bioscience, CAT#861-20) |
| Z-Glu-Ala-Asp-CHO (Echelon Bioscience, CAT#878-05) |
| Z-Gly-Gly-Arg-AMC (Urokinase Substrate III, fluorogenic) (Echelon Bioscience, CAT#869-25) |
| Z-Gly-Gly-Leu-AMC (Proteasome Substrate, fluorogenic) (Echelon Bioscience, CAT#882-31) |
| Z-Gly-Val-Val-AMC (Echelon Bioscience, CAT#877-04) |
| Z-Ile-Glu-Thr-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-56) |
| Z-Ile-Glu-Thr-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#863-61) |
| Z-Leu-Arg-AMC (Cathepsin, Kallikrein, Falcipain II substrate, fluorogenic) (Echelon Bioscience, CAT#877-14) |
| Z-Leu-Leu-Glu-AMC (Proteasome Substrate 2, fluorogenic) (Echelon Bioscience, CAT#882-21) |
| Z-Leu-Leu-Leu-AMC (Proteasome Substrate 1, fluorogenic) (Echelon Bioscience, CAT#882-20) |
| Z-Leu-Leu-Phe-CHO (Proteasome Inhibitor 2) (Echelon Bioscience, CAT#882-12) |
| Z-Phe-Ala-pNA (Echelon Bioscience, CAT#876-05) |
| Z-Phe-Arg-AFC (Cathepsin L Substrate, fluorogenic) (Echelon Bioscience, CAT#866-75) |
| Z-Phe-Arg-AMC (Kallikrein substrate) (Echelon Bioscience, CAT#871-75) |
| Z-Phe-CHO (Echelon Bioscience, CAT#878-06) |
| Z-Phe-Tyr-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-28) |
| Z-Tyr-Val-Ala-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-17) |
| Z-Tyr-Val-Ala-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-28) |
| Z-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-49) |
| Z-Val-Gly-Arg-pNA (Urokinase Substrate I, colorimetric) (Echelon Bioscience, CAT#869-31) |
| Z-Val-Ile-Ala-AMC (IRCM Serine Protease I Substrate, fluorogenic) (Echelon Bioscience, CAT#877-05) |
| Z-Val-Lys-Met-AMC (Proteasome Substrate 4, fluorogenic) (Echelon Bioscience, CAT#882-23) |
| Z-Val-Phe-CHO (Calpain Inhibitor III) (Echelon Bioscience, CAT#870-50) |
| Z-Val-Pro-Arg-pNA (Echelon Bioscience, CAT#876-08) |
| Z-Val-Val-Arg-AFC (Echelon Bioscience, CAT#874-01) |
| Zn (II) Deuteroporphyrin IX 2,4 bisethylene glycol (Echelon Bioscience, CAT#F-H090) |
| Zn Protoporphyrin IX (Echelon Bioscience, CAT#F-H060) |
| ZSTK474 (PI3K Inhibitor) (Echelon Bioscience, CAT#B-0307) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Echelon Biosciences"> Echelon Biosciences
<艾美捷科技代理Akina品牌全系列产品
Akina, Inc. 于2001年成立，是一家具有多年经营历史的公司，PolyScitech作为其旗下部门，依托公司的资源和平台开展业务。由Kinam Park博士创立，他是普渡大学生物医学工程与药剂学教授。Kinam Park博士在相关学术领域具有深厚的造诣和丰富的经验，这为PolyScitech部门在技术研发和专业方向上提供了坚实的学术支持和引领。Akina公司的产品线包括：PolySciTech Polymers、PURASORB® Polymers、Viatel™m Polymers、VIVOS™ PLGA-g-PEG、PLGA/PLA Standards、NuPlonTm、AquaGel@ Hydrogels、PET Prepolymer、Flamma Fluor Fluorescent Dyes、Kitopure Chitosan、3DCellMaker。
Akinalytics作为Akina, Inc.的部门，专门从事控释药物输送系统以及可生物降解聚合物及其制药/生物医学应用。提供快速周转和具有竞争力的价格的样品分析，包括FTIR分光光度法、紫外/可见分光光度法、GPC、调制差示扫描量热法、流变分析、机械/纹理分析、光学分析等。
▍Akina公司产品线
● PolySciTech Polymers：提供各种类型的聚合物产品，广泛应用于科研和工业领域
● PURASORB® Polymers：由于Corbion和Akina, Inc. (PolySciTech) 之间的分销关系，Purasorb®聚合物现作为研究产品提供，简化开发项目。用于长效注射剂、医疗器械等，为GMP制造的产品提供临床转化的直接途径。
● Viatel™ Polymers：精选开发产品，得益于Ashland和Akina, Inc. (PolySciTech) 之间的分销关系。无最低订购量要求，购买时间快，便利开发需求。
● VIVOS™ PLGA-g-PEG：使用聚丙交酯-乙醇共聚酯-接枝-聚乙二醇组成的快速溶解、可生物降解的热凝胶输送活性药物。由Vivos, Inc.和Akina, Inc.合作开发，简化药物递送开发。
产品应用：这些聚合物产品具有多种应用，包括但不限于阴离子药物/核酸衍生物的递送；纳米通道和纳米孔的形成；形成“隐形”聚乙二醇化微粒；聚合物混合物的塑化（不溶性）；用于改性/交联的短链树脂；热凝胶化；药物的水溶性
▍Akina部分产品列表
<| 货号 | 品名 | 规格 | Mw |
| AK001 | Methoxy poly(ethylene glycol)-b-poly(caprolactone) | 5g;10g;25g | ~2,000:5,200 Da |
| AK002 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:4,110 Da |
| AK003 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:1,700 Da |
| AK004 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:5,000 Da |
| AK005 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,000:10,000 Da |
| AK006 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~750:5,600 Da |
| AK007 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~5,000:4,900 Da |
| AK008 | Poly(L-lactide)-b-poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~2,400:2,000:2,400 Da |
| AK009 | Methoxy poly(ethylene glycol)-b-poly(D,L-lactide) | 5g;10g;25g | ~2,000:2,200 Da |
| AK010 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:10,000 Da |
| AK011 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,600:1,000:1,600 Da |
| AK012 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,000:1,000:1,000 Da |
| AK013 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:400:2,000 Da |
| AK014 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~400:400:400 Da |
| AK015 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:1,000:5,000 Da |
| AK016 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~70,000:4,600:70,000 Da |
| AK019 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,500:1,500:1,500 Da |
| AK021 | Methoxy poly(ethylene glycol)-b-poly(D,L-lactide) | 5g;10g;25g | ~5,000:50,000 Da |
| AK023 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:1,500 Da |
| AK024 | Poly(lactide-co-glycolide)-b-poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~1,100:1,000:1,100 Da |
| AK025 | Methoxy poly(ethylene glycol)-b-poly(L-lactide) | 5g;10g;25g | ~750:1,000 Da |
| AK026 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~5,000:55,000 Da |
| AK027 | Methoxy poly(ethylene glycol)-b-poly(lactide-co-glycolide) | 5g;10g;25g | ~2,000:15,000 Da |
| AK028 | Poly(lactide-co-caprolactone)-b-poly(ethylene glycol)-b-poly(lactide-co-caprolactone) | 5g;10g;25g | ~5,700:4,600:5,700 Da |
艾美捷科技代理Protein Ark品牌产品。
Protein Ark公司提供全流程的样品制备产品、分离试剂盒和定制服务，以协助用户开展从克隆到蛋白质以及从肽到抗体的研究。
产品范围包括：
（1）DNA电泳：Elite DNA分子量标准，Elite琼脂糖片；
（2）蛋白表达试剂：培养基优化试剂盒™，Dream™ Overnight SelenoMet Expression Media，IPTG，TCEP；
（3）蛋白纯化缓冲液：缓冲液，标准裂解、结合、洗涤和洗脱缓冲液，FLAG肽；
（4）亲和层析填料：用于抗体纯化的蛋白A和蛋白G，固定化金属亲和层析（IMAC），Fastback Ni Advance填料，GST和肝素亲和层析填料；
（5）IEX层析树脂：离子交换树脂；
（6）HIC层析填料：HIC培养基通常在中高盐浓度下结合；
（7）活化层析填料：具有多种偶联化学成分的各种活化培养基，可高效、快速、轻松、安全地固定各种功能配体；
（8）Annex病毒纯化层析填料：Annex VP系列层析介质具有薄的多孔惰性外壳，可排除分子量分别为>5000kDa、>700kDa、>400kDa的分子；
（9）内毒素清除树脂：用于去除特定内毒素的NoEndo™树脂，NoEndoTM试剂盒；
（10）Proteus离心柱试剂盒：Proteus蛋白A和G、Ni-IMAC试剂盒；
（11）Proteus洗涤剂交换迷你离心柱；
（12）预填充色谱柱：HiFliQ FPLC色谱柱；
（13）定制色谱柱填料：色谱柱硬件足够坚固，可进行多次使用和原位清洗，并且价格合理，可用作实验室规模、生物工艺和GMP应用的一次性色谱柱；
（14）体积排除柱
（15）空纯化柱：Proteus 一步批处理离心柱，Proteus FliQ FPLC Columns；
（16）样品制备：Proteus Mini 澄清离心柱；
（17）浓缩：变形杆菌X-微调器超滤浓缩器；
（18）蛋白质电泳：实时染色，Elite预染蛋白分子量标准，Eco预染蛋白质分子量标准；
（19）快速考马斯蛋白染色；
（20）蛋白质印迹底物。
< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Protein Ark品牌产品。"> 艾美捷科技代理Protein Ark品牌产品。
<艾美捷科技代理Innovotech品牌全系列产品
Innovotech公司专注于抗菌及生物膜解决方案领域。公司在标准化和定制化研究领域拥有卓越业绩，始终致力于满足客户需求。Innovotech的合同研究服务涵盖全周期：从早期问题识别与"抗生物膜活性"制剂筛选，到符合监管机构要求的产品宣称验证研究，再到用于营销推广的上市后产品比对研究。公司常规开发客户定制化体外模型作为研究起点，支持多维度测试参数的全面检测。
Innovotech的研发体系主要建立在两大专利技术平台：MBEC检测法®（最小生物膜根除浓度测定）和BEST检测法™（生物膜表观生存力检测）。基于这些平台，公司已开发出系列独特检测方法，适用于医疗、牙科、农业及工业领域中各类溶液态抗菌剂与表面涂层抗菌剂的测试。公司还融合平台技术与生物膜、医疗器械及银化学等领域的专业知识，开发出自有抗生物膜产品线：InnovoSIL™系列在医疗器械应用领域展现显著潜力，AgreGuard™-1在农业应用测试中验证卓越效力。Innovotech已构建测试平台的生物膜问题涉及导管及植入式医疗器械、抗生素药物研发、伤口愈合管理、特种涂料与防护涂层、水系统抗菌解决方案、牙科治疗及供水管线抗菌方案、农作物细菌/真菌病害防治、食品加工硬表面消毒剂等领域。
▍Innovotech产品列表
| 品名 | 产品描述 | 货号 |
| MBEC Assay® Biofilm Inoculator with Trough Base & Cellulose Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. This MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 cellulose-coated pegs and a trough base. One of its recommended uses is with plant pathogens. | 10/cs：19193；25/cs：19191；100/cs：19192 |
| MBEC Assay® Biofilm Inoculator with 96 Well Base & Cellulose Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. This MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 cellulose-coated pegs and a well base. One of its recommended uses is with plant pathogens. | 10/cs：19173；25/cs：19171；100/cs：19172 |
| MBEC Assay® Biofilm Inoculator with Trough Base & Titanium Dioxide Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a Titanium Dioxide coated well base. | 10/cs：19163；25/cs：19161；100/cs：19162 |
| MBEC Assay® Biofilm Inoculator with 96 Well Base & Titanium Dioxide Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 Titanium Dioxide coated pegs and a well base. | 10/cs：19153；25/cs：19151；100/cs：19152 |
| MBEC Assay® Biofilm Inoculator with Trough Base & Hydroxyapatite Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a Hydroxyapatite coated a well base. | 10/cs：19143；25/cs：19141；100/cs：19142 |
| MBEC Assay® Biofilm Inoculator with 96 Well Base & Hydroxyapatite Coated Pegs | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 Hydroxyapatite coated pegs and a well base. | 10/cs：19133；25/cs：19131；100/cs：19132 |
| MBEC Assay® Biofilm Inoculator with Trough Base | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with a trough base. | 10/cs：19123；25/cs：19121；100/cs：19122 |
| MBEC Assay® Biofilm Inoculator with 96 Well Base | The MBEC Assay® Biofilm Inoculator is a high throughput screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms. The MBEC Assay® Biofilm Inoculator consists of a plastic lid with 96 pegs well base. | 10/cs：19113；25/cs：19111；100/cs：19112 |
| InnovoSIL™-1 silver | The InnovoSIL™ family consists of novel antimicrobial silver complexes. InnovoSIL™-1 Antimicrobial Silver is ideally suited to coating onto or incorporating into medical devices, and is ready for testing. | - |
LGC标准物质公司隶属于LGC集团，专注于化学和生物分析，是世界领先的实验室服务、检测服务、标准物质服务、基因组服务提供商，涉及的行业包括石化、食品&饮料、临床、环境、制药、法医和生命科学等。
LGC Standard的主要产品包括：
Products and services
ATCC and Life sciences
Elemental Analysis
Food, beverages and environment
Clinical Forensic and Phytochemicals
Petroleum Standards and CRMs
Pharmaceutical
Proficiency Testing
Solvents
Training
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LGC Standards"> LGC Standards
艾美捷科技代理Oxford Expression Technologies品牌。
Oxford Expression Technologies（英国）位于英国牛津，为全球制药和生物技术行业提供产品，服务和咨询服务。OET专门从事重组蛋白表达，其核心技术flashBACTM是一种基于杆状病毒
的蛋白表达系统，能快速生产适用于小型和大型蛋白表达系统的多种重组病毒。
OET产品还涉及昆虫和哺乳动物表达系统中的载体、转染试剂和培养基。
< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Oxford Expression Technologies品牌"> 艾美捷科技代理Oxford Expression Technologies品牌
艾美捷科技代理Gene Bridges品牌。
Gene Bridges是一家专注于基因工程和分子克隆技术的公司，提供创新的基因组编辑工具和解决方案，支持基础研究、生物技术和药物开发。Gene Bridges公司采用 Red/ET 重组技术，实现高效、精确的基因组编辑；提供灵活的定制基因组编辑和分子克隆服务，满足客户需求。Gene Bridges公司产品用于基因功能研究、基因组学和分子生物学研究；生物制药、基因治疗和合成生物学；药物靶点验证、基因敲除模型构建和药物筛选；用于作物改良、基因编辑和转基因研究。
其主要产品与服务：
（1）Red/ET 重组技术：提供基于 Red/ET 重组技术的基因工程工具，用于高效、精确的基因组编辑。
（2）分子克隆试剂盒：提供多种分子克隆试剂盒，包括 DNA 片段克隆、基因敲除和基因插入试剂盒。
（3）定制基因组编辑服务：根据客户需求，提供定制化的基因组编辑和分子克隆服务。
（4）技术咨询与支持：提供基因工程和分子克隆相关的咨询和技术支持服务。
艾美捷科技代理Crystal Positioning Systems (CPS)品牌。
Crystal Positioning Systems (CPS)是专业蛋白结晶设备生厂商，包括：Puck 样品槽、液氮箱、运输箱、样品储存和转移用的工具。Crystal Positioning Systems (CPS) 是一家专注于为X射线晶体学和结构生物学领域提供高精度样品定位和自动化解决方案的公司，CPS 的产品旨在帮助科学家在蛋白质晶体学、材料科学和其他相关领域的研究中，实现更高效、更精确的样品定位和数据收集。公司以其创新的技术、高质量的产品和对客户需求的深刻理解而闻名。核心业务领域：
（1）高精度样品定位系统：CPS 提供用于X射线衍射仪的高精度样品定位系统，支持蛋白质晶体和小分子晶体的精确对准。这些系统能够显著提高数据收集的效率和准确性。
（2）自动化晶体成像系统：公司开发了自动化晶体成像系统，用于实时监测晶体生长过程，帮助科学家优化晶体生长条件。这些系统通常与X射线衍射仪集成，支持从晶体生长到数据收集的全流程自动化。
（3）机器人样品处理系统：CPS 提供机器人样品处理系统，用于高通量晶体筛选和数据收集。这些系统能够自动处理大量样品，显著提高实验效率。
" data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Crystal Positioning Systems (CPS)品牌"> 艾美捷科技代理Crystal Positioning Systems (CPS)品牌
Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品，应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。
Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.
Anogen的主要产品包括：
Monoclonal Antibodies
Polyclonal Antibodies
Matched Antibody Pairs
ELISA Kits
按照研究领域细分：
Inflammatory & Growth Factors
Cell Biology & Molecular Biology
Immunoassay Reagents
Infection & Toxin
Coagulation Factors
Hormone
Neurological Disorder
Tumor Research
| 品名 | 货号 | 规格 |
| mAb anti-Human TNF-α, CH8810 | MO-C40003A | 0.1 mg |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, C2H9 | MO-C40003D | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, C2A7 | MO-C40003F | 0.1 mg |
| mAb anti-Human TNF-α, C5G7 | MO-C40003G | 0.1 mg |
| mAb anti-Human TNF-α, C4C7 | MO-C40003H | 0.1 mg |
| mAb anti-Human IFN-γ, 315 | MO-C40004D | 0.1 mg |
| mAb anti-Human IFN-γ, 165 | MO-C40004E | 0.1 mg |
| mAb anti-Human IFN-γ, 23 | MO-C40004F | 0.1 mg |
| mAb anti-Human CCR1, 293 | MO-C40005A | 0.1 mg |
| mAb anti-Human TGF-β, TB21 | MO-C40009A | 0.1 mg |
| mAb anti-Human TGF-β, 2C5 | MO-C40009B | 0.1 mg |
| mAb anti-Human TGF-β, 2C6 | MO-C40009D | 0.1 mg |
| mAb anti-Human TGF-β, 2E6 | MO-C40009E | 0.1 mg |
| mAb anti-Human TGF-β, 8C4 | MO-C40009F | 0.1 mg |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-61 | MO-C40017E | 0.1 mg |
| mAb anti-Human IL-8, 257 | MO-C40017F | 0.1 mg |
| mAb anti-Human IL-8, 807 | MO-C40017G | 0.1 mg |
| mAb anti-Human MCP-1, S8 | MO-C40021A | 0.1 mg |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, 9G10 | MO-C40021E | 0.1 mg |
| mAb anti-Human MCP-1, S382 | MO-C40021F | 0.1 mg |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 513 | MO-C40028D | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 291 | MO-C40028G | 0.1 mg |
| mAb anti-Human SAA, 504 | MO-C40028H | 0.1 mg |
| mAb anti-Human SAA, 585 | MO-C40028J | 0.1 mg |
| mAb anti-Human SAA, 426 | MO-C40028K | 0.1 mg |
| mAb anti-Human SAA, 38 | MO-C40028L | 0.1 mg |
| mAb anti-Human SAA, 132 | MO-C40028M | 0.1 mg |
| mAb anti-Human SAA, S3 | MO-C40028N | 0.1 mg |
| mAb anti-Human IL-1β, S1H12 | MO-C40029A | 0.1 mg |
| mAb anti-Human IL-1β, S1B7 | MO-C40029B | 0.1 mg |
| mAb anti-Human IL-1β, S3F12 | MO-C40029G | 0.1 mg |
| mAb anti-Human IL-1β, 464 | MO-C40029H | 0.1 mg |
| mAb anti-Human IL-2, 5A8, | MO-C40032A | 0.1 mg |
| mAb anti-Human IL-2, 9F9, | MO-C40032B | 0.1 mg |
| mAb anti-Human IL-2, 10C4 | MO-C40032C | 0.1 mg |
| mAb anti-Human IL-2, 8C2 | MO-C40032D | 0.1 mg |
| mAb anti-Human IL-2, 6F11 | MO-C40032E | 0.1 mg |
| mAb anti-Human IL-2, 6B1 | MO-C40032F | 0.1 mg |
| mAb anti-Human EGF, S-21 | MO-C40044A | 0.1 mg |
| mAb anti-Human EGF, S-120 | MO-C40044B | 0.1 mg |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-145 | MO-C40044E | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-147 | MO-C40044G | 0.1 mg |
| mAb anti-Human EGF, S-177 | MO-C40044H | 0.1 mg |
| mAb anti-Human G-CSFR, S-1252 | MO-C40045A | 0.1 mg |
| mAb anti-Human G-CSFR, S-1268 | MO-C40045B | 0.1 mg |
| mAb anti-Human G-CSFR, S-1284 | MO-C40045D | 0.1 mg |
| mAb anti-Human G-CSFR, S-1374 | MO-C40045E | 0.1 mg |
| mAb anti-Human G-CSFR, S-425 | MO-C40045F | 0.1 mg |
| mAb anti-Human G-CSFR, S-1390 | MO-C40045G | 0.1 mg |
| mAb anti-Human bFGF, F-343 | MO-C40046A | 0.1 mg |
| mAb anti-Human bFGF, F-74 | MO-C40046B | 0.1 mg |
| mAb anti-Human bFGF, F-474 | MO-C40046F | 0.1 mg |
| mAb anti-Human bFGF, F-3 | MO-C40046H | 0.1 mg |
| mAb anti-Human EPO, 85 | MO-C40047A | 0.1 mg |
| mAb anti-Human M-CSF, 116 | MO-C40048A | 0.1 mg |
| mAb anti-Human M-CSF, 692 | MO-C40048B | 0.1 mg |
| mAb anti-Human M-CSF, 21 | MO-C40048D | 0.1 mg |
| mAb anti-Human MIP-1α, 116 | MO-C40051A | 0.1 mg |
| mAb anti-Human MIP-1α, 125 | MO-C40051D | 0.1 mg |
| mAb anti-Human MIP-1α, 548 | MO-C40051F | 0.1 mg |
| mAb anti-Human MIP-1α, 199 | MO-C40051G | 0.1 mg |
| mAb anti-Human MIP-1α, 400 | MO-C40051L | 0.1 mg |
| mAb anti-Human MIP-1α, 103 | MO-C40051M | 0.1 mg |
| mAb anti-Human MIP-1α, 376 | MO-C40051N | 0.1 mg |
| mAb anti-Human MIP-1α, 426 | MO-C40051P | 0.1 mg |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 343 | MO-C40088B | 0.1 mg |
| mAb anti-Human MCP-3, 490 | MO-C40088D | 0.1 mg |
| mAb anti-Human MCP-3, 768 | MO-C40088E | 0.1 mg |
| mAb anti-Human MCP-3, 1057 | MO-C40088F | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 1015 | MO-C40088H | 0.1 mg |
| mAb anti-Human IL-16, 59 | MO-C40089G | 0.1 mg |
| mAb anti-Human IL-16, 210 | MO-C40089H | 0.1 mg |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 568 | MO-C40089M | 0.1 mg |
| mAb anti-Human IL-16, 572 | MO-C40089N | 0.1 mg |
| mAb anti-Human GM-CSF, 29 | MO-C40090A | 0.1 mg |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 204 | MO-C40090E | 0.1 mg |
| mAb anti-Human GM-CSF, 489 | MO-C40090F | 0.1 mg |
| mAb anti-Human GM-CSF, 120 | MO-C40090G | 0.1 mg |
| mAb anti-Human GM-CSF, 26 | MO-C40090H | 0.1 mg |
| mAb anti-Human GM-CSF, 174 | MO-C40090K | 0.1 mg |
| mAb anti-Human GM-CSF, S333 | MO-C40090L | 0.1 mg |
| mAb anti-Human IL-6, 2E10 | MO-C40091B | 0.1 mg |
| mAb anti-Human IL-6, 8E10 | MO-C40091C | 0.1 mg |
| mAb anti-Human IL-6, 5G8 | MO-C40091D | 0.1 mg |
| mAb anti-Human IL-6, 1B6 | MO-C40091E | 0.1 mg |
| mAb anti-Human IL-6, 1E3 | MO-C40091F | 0.1 mg |
| mAb anti-Human IL-6, 6D7 | MO-C40091G | 0.1 mg |
| mAb anti-Human IL-6, 9D8 | MO-C40091H | 0.1 mg |
| mAb anti-Human IL-10, 4H2 | MO-C40092A | 0.1 mg |
| mAb anti-Human IL-10, 6D2 | MO-C40092B | 0.1 mg |
| mAb anti Human IL-17A clone 4C1, Capture | MO-C40093A | 0.1mg |
| mAb anti Human IL-17A clone 2F3 | MO-C40093B | 0.1mg |
| mAb anti Human IL-17A clone 8H7 | MO-C40093C | 0.1mg |
| mAb anti Human IL-17A clone 5B4 | MO-C40093D | 0.1mg |
| mAb anti Human IL-17A clone 1E2 | MO-C40093E | 0.1mg |
| mAb anti Human IL-17A clone 2D11 | MO-C40093H | 0.1mg |
| mAb anti Human IL-17A clone 3C1 | MO-C40093I | 0.1mg |
| mAb anti Human IL-17A clone 3H11, Detector | MO-C40093K | 0.1mg |
| mAb anti Human IL-17A clone 5A9 | MO-C40093M | 0.1mg |
| mAb anti Human IL-17A clone 6F12 | MO-C40093O | 0.1mg |
| mAb anti Human IL-17A clone 7F10 | MO-C40093S | 0.1mg |
| mAb anti Human IL-17A clone 10F9 | MO-C40093W | 0.1mg |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti-human LIF, Clone 2C6 | MO-C40096A | 0.1mg |
| mAb anti-human LIF, Clone 3F4 | MO-C40096B | 0.1mg |
| mAb anti-human LIF, Clone 8B10 | MO-C40096C | 0.1mg |
| mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4 | MO-H40001B | 0.1 mg |
| mAb anti-GAPDH, H8 | MO-H40002A | 0.1 mg |
| mAb anti-HA Tag, HA52 | MO-H40004A | 0.1 mg |
| mAb anti-His Tag, 10A12 | MO-H40005B | 0.1 mg |
| mAb anti-Myc Tag, MycA7 | MO-H40006A | 0.1 mg |
| mAb anti-V5 Tag, V531 | MO-H40007A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 163 | MO-I40002C | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mg | MO-I40002E | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 425 | MO-I40002I | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 1027 | MO-I40002J | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 287 | MO-I40002N | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 161 | MO-I40002P | 0.1 mg |
| mAb anti-HBsAg, RM-1 | MO-I40013A | 0.1 mg |
| mAb anti-HCV Core Protein, A1/3D1 | MO-I40015A | 0.1 mg |
| mAb anti-HCV Core Protein, B2 | MO-I40015B | 0.1 mg |
| mAb anti-HCV Core Protein, C3 | MO-I40015E | 0.1 mg |
| mAb anti-HCV NS-4, 7B7/5G9 | MO-I40016B | 0.1 mg |
| mAb anti-HCV NS-4, 5D4/10E7 | MO-I40016D | 0.1 mg |
| mAb anti-HCV NS-4, 7E11 | MO-I40016F | 0.1 mg |
| mAb anti-HCV NS-4, 202 | MO-I40016J | 0.1 mg |
| mAb anti-HCV NS-4, 101 | MO-I40016K | 0.1 mg |
| mAb anti-HCV NS-4, 174 | MO-I40016L | 0.1 mg |
| mAb anti-HCV NS-4, 497 | MO-I40016M | 0.1 mg |
| mAb anti-HCV NS-3, 70-13 | MO-I40018A | 0.1 mg |
| mAb anti-HCV NS-3, 1-5 | MO-I40018B | 0.1 mg |
| mAb anti-HCV NS-3, 12-15 | MO-I40018D | 0.1 mg |
| mAb anti-HCV NS-3, 5-11 | MO-I40018E | 0.1 mg |
| mAb anti-HCV NS-3, 24-8 | MO-I40018F | 0.1 mg |
| mAb anti-HCV NS-3, 20-8 | MO-I40018G | 0.1 mg |
| mAb anti-HCV NS-3, 113 | MO-I40018H | 0.1 mg |
| mAb anti-HCV NS-3, 281 | MO-I40018J | 0.1 mg |
| mAb anti-HCV NS-3, 806 | MO-I40018K | 0.1 mg |
| mAb anti-HCV NS-3, 5 | MO-I40018L | 0.1 mg |
| mAb anti-HCV NS-3, 328 | MO-I40018M | 0.1 mg |
| mAb anti-HCV NS-3, 251 | MO-I40018N | 0.1 mg |
| mAb anti-HCV NS-3, 242 | MO-I40018P | 0.1 mg |
| mAb anti-HCV NS-3, 133 | MO-I40018Q | 0.1 mg |
| mAb anti-HEV, S-13 | MO-I40019B | 0.1 mg |
| mAb anti-HEV, 4H5 | MO-I40019C | 0.1 mg |
| mAb anti-HEV, 2H6 | MO-I40019D | 0.1 mg |
| mAb anti-HEV, 2H2 | MO-I40019E | 0.1 mg |
| mAb anti-HEV, 1B6 | MO-I40019F | 0.1 mg |
| mAb anti-HEV, 5H4 | MO-I40019G | 0.1 mg |
| mAb anti-HP CagA, 10E9, | MO-I40020A | 0.1 mg |
| mAb anti-HP CagA, 5H10 | MO-I40020B | 0.1 mg |
| mAb anti-HP CagA, 5C6 | MO-I40020C | 0.1 mg |
| mAb anti-HP CagA, 3C10, | MO-I40020D | 0.1 mg |
| mAb anti-HP CagA, 3C1 | MO-I40020E | 0.1 mg |
| mAb anti-TB 38KD Antigen, D2G2 | MO-I40021A | 0.1 mg |
| mAb anti-TB 38KD Antigen, C12H11 | MO-I40021B | 0.1 mg |
| mAb anti-TB 38KD Antigen, C11B10 | MO-I40021C | 0.1 mg |
| mAb anti-TB 38KD Antigen, B12F8 | MO-I40021D | 0.1 mg |
| mAb anti-TB 38KD Antigen, A11D2 | MO-I40021E | 0.1 mg |
| mAb anti-TB 38KD Antigen, A2H8 | MO-I40021F | 0.1 mg |
| mAb anti-Human CD3, JXT3 | MO-L40001A | 0.1 mg |
| Rat anti-Mouse CD4, JXYT4 | MO-L40026 | 0.1 mg |
| Rat anti-Mouse CD8, JXYT8 | MO-L40027 | 0.1 mg |
| mAb anti-Human CD11α, A11 | MO-L40028 | 0.1 mg |
| mAb anti-Human HLA-ABC, LY5.1 | MO-L40033 | 0.1 mg |
| mAb anti-Human CD71 Transferrin Receptor, CY-TFR | MO-L40042 | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 1C4 | MO-L40043A | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7C9, Capture | MO-L40043B | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9E11 | MO-L40043E | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9B4 | MO-L40043F | 0.1 mg |
| mAb anti-Human PD-1 / CD279, B1C4 | MO-L40043G | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7G12, Detector | MO-L40043L | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 2H7 | MO-L40043M | 0.1 mg |
| mAb anti Human PD-L1, clone 6A5 | MO-L40044E | 0.1 mg |
| mAb anti Human PD-L1 clone 8C12 | MO-L40044F | 0.1 mg |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 11D11 | MO-L40044M | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti Human PD-L1 clone 12D9 | MO-L40044O | 0.1 mg |
| mAb anti Human PD-L1 clone 15F2 | MO-L40044R | 0.1 mg |
| mAb anti Human PD-L1, clone 10B12 | MO-L40044S | 0.1 mg |
| mAb anti Human CD47, clone 1G10 | MO-L40045A | 0.1 mg |
| mAb anti Human CD47, clone 8H7 | MO-L40045B | 0.1 mg |
| mAb anti Human CD47, clone 9F10 | MO-L40045C | 0.1 mg |
| mAb anti Human CD44, clone 2G7 | MO-L40046A | 0.1 mg |
| mAb anti Human CD44, clone 3C7 | MO-L40046B | 0.1 mg |
| mAb anti-hCG-α, CH5 | MO-M40010A | 0.1 mg |
| mAb anti-hCG-α, CH7 | MO-M40010B | 0.1 mg |
| mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mg | MO-M40011A | 0.1 mg |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-Human Ig Kappa Light Chain, YCK1 | MO-M40020 | 0.1 mg |
| mAb anti-Human B2MG, D6E4 | MO-M40021B | 0.1 mg |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D6D1 | MO-M40021D | 0.1 mg |
| mAb anti-Human B2MG, D2A10 | MO-M40021E | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human CRP, 67A1 | MO-M40023B | 0.1 mg |
| mAb anti-human CRP, N1G1 | MO-M40023D | 0.1 mg |
| mAb anti-human CRP, S5G1 | MO-M40023E | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1C6, 0.1 mg | MO-M40025A | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1E6, 0.1 mg | MO-M40025B | 0.1 mg |
| mAb Rat anti-Aflatoxin, 2E4 | MO-M40025D | 0.1 mg |
| mAb anti-Human Albumin, S4D6 | MO-M40036 | 0.1 mg |
| mAb anti-Human Factor IX, F9-1, .01 mg | MO-M40037 | 0.1 mg |
| mAb anti-Human Protein C, HLW-C, 0.1 mg | MO-M40038 | 0.1 mg |
| mAb anti-Human Factor X, F10-1, 0.1 mg | MO-M40039 | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 237, 0.1 mg | MO-M40040A | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 474, 0.1 mg | MO-M40040B | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, Y8 | MO-M40040D | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 700 | MO-M40040E | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 585 | MO-M40040F | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 8 | MO-M40040H | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 291 | MO-M40040J | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 262 | MO-M40040N | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 71 | MO-M40040Q | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 128 | MO-M40040S | 0.1 mg |
| mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mg | MO-M40041 | 0.1 mg |
| mAb anti-Human PTP1-C, PTY6 | MO-M40043A | 0.1 mg |
| mAb anti-Human PTP1-C, PTY11 | MO-M40043B | 0.1 mg |
| mAb anti-Human PTP1-C, PTY15 | MO-M40043D | 0.1 mg |
| mAb anti-Human PTP1-C, PTY10 | MO-M40043E | 0.1 mg |
| mAb anti-Human PTP1-C, PTY13 | MO-M40043F | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human Raf-1, 410 | MO-M40091E | 0.5 mg |
| mAb anti-Human Raf-1, 540 | MO-M40091G | 0.5 mg |
| mAb anti-Human Raf-1, 863 | MO-M40091J | 0.5 mg |
| mAb anti-Human Raf-1, 163 | MO-M40091M | 0.5 mg |
| mAb anti-Human NSE, 145 | MO-M40092A | 0.5 mg |
| mAb anti-Human NSE, 1G6 | MO-M40092B | 0.5 mg |
| mAb anti-Human NSE, 171 | MO-M40092C | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3B3 | MO-M40093A | 0.1 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3F8 | MO-M40093D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 3F5 | MO-M40094A | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1H3 | MO-M40094B | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 6C8 | MO-M40094C | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4A2 | MO-M40094E | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7H7 | MO-M40094F | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5A4 | MO-M40094G | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4B7 | MO-M40094H | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7G10 | MO-M40094I | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1F10 | MO-M40094J | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 8B2 | MO-M40095B | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, 4B1 | MO-M40095C | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 5G5 | MO-M40096A | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 9F2 | MO-M40096B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4H11 | MO-M40097A | 0.1 mg |
| mAb anti-Human α-Synuclein, 4C1 | MO-M40097B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4B4 | MO-M40097C | 0.1 mg |
| mAb anti-Human α-Synuclein, 8F12 | MO-M40097D | 0.1 mg |
| mAb anti-Human α-Synuclein, 9A9 | MO-M40097E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, 3E11 | MO-M40098A | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B2B3 | MO-M40098B | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B4H12 | MO-M40098C | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B5B11 | MO-M40098D | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7B10 | MO-M40098E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7H2 | MO-M40098F | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 1A4 | MO-M40099A | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 7G9 | MO-M40099B | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 9B4 | MO-M40099C | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 2A4 | MO-M40099D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1 | MO-M40100A | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8 | MO-M40100B | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1 | MO-M40100C | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12 | MO-M40100D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1 | MO-M40100E | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11 | MO-M40100F | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11 | MO-M40100G | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9 | MO-M40100H | 0.1 mg |
| mAb anti-LCRMP4, 5H5 | MO-M40101A | / |
| mAb anti-LCRMP4, 2H7 | MO-M40101B | / |
| mAb anti-LCRMP4 , 7E1 | MO-M40101C | / |
| mAb anti-Human Phospho-STAT5b [p-Y699], A4B9 | MO-P40001A | 0.1 mg |
| mAb anti-Human Phospho-STAT5b [p-Y699], A2H6 | MO-P40001B | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], B4A12 | MO-P40002A | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], D7H2 | MO-P40002B | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], A3A4 | MO-P40003A | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], B1C4 | MO-P40003B | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, C4F9 | MO-P40006A | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, B4D9B10 | MO-P40006B | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, 3D7 | MO-P40007A | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, B7H10 | MO-P40007B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, CHALU2 | MO-T40005B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, 3504 | MO-T40005C | 0.1 mg |
| mAb anti-Human Hepatocellular Carcinoma, CHALV1 | MO-T40006A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human BPH, YBPH-1 | MO-T40008A | 0.1 mg |
| mAb anti-Human BPH, YBPH-2 | MO-T40008B | 0.1 mg |
| mAb anti-Human PML, B3E9 | MO-T40010A | 0.1 mg |
| mAb anti-Human PML, B4C8 | MO-T40010B | 0.1 mg |
| mAb anti-CA 125, 110 | MO-T40012A | 0.1 mg |
| mAb anti-CA 125, 76 | MO-T40012B | 0.1 mg |
| mAb anti-CA 125, 23 | MO-T40012C | 0.1 mg |
| mAb anti-CA 125, 15 | MO-T40012D | 0.1 mg |
| mAb anti-CA 125 | MO-T40012E | 0.1 mg |
| mAb anti-CA50, 93 | MO-T40014A | 0.1 mg |
| mAb anti-CA50, 826 | MO-T40014B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available) | MO-T40015A | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available) | MO-T40015B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available) | MO-T40015C | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available) | MO-T40015D | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available) | MO-T40015E | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available) | MO-T40015F | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available) | MO-T40015G | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma, Y94 | MO-T40022 | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma/CD3, BS-1 | MO-T40035 | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PMA, YPMA-1 | MO-T40083A | 0.1 mg |
| mAb anti-Human PMA, YPMA-2 | MO-T40083B | 0.1 mg |
| mAb anti-Human PSP, YPSP-1 | MO-T40085A | 0.1 mg |
| mAb anti-Human PSP, YPSP-2 | MO-T40085B | 0.1 mg |
| mAb anti-Human PSP, YPSP-3 | MO-T40085C | 0.1 mg |
| mAb anti-Human PSP, YPSP-4 | MO-T40085D | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-1 | MO-T40086A | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-2 | MO-T40086B | 0.1 mg |
| mAb anti-Human PSMA, 4H11 | MO-T40086C | 0.1 mg |
| mAb anti-Human PSMA, 7F3 | MO-T40086D | 0.1 mg |
| mAb anti-Human PTMA, 8H12 | MO-T40087A | 0.1 mg |
| mAb anti-Human PTMA, 9A10 | MO-T40087B | 0.1 mg |
| mAb anti-Human PTMA, 6A3 | MO-T40087C | 0.1 mg |
| mAb anti-Human PTMA, 4G2 | MO-T40087D | 0.1 mg |
| mAb anti-Human PTMA, 5A10 | MO-T40087E | 0.1 mg |
| mAb anti-Human PTMA, 6H7 | MO-T40087F | 0.1 mg |
| mAb anti-Human PTMA, 1F2, Capture | MO-T40087G | 0.1 mg |
| mAb anti-Human PTMA, 4C3 | MO-T40087H | 0.1 mg |
| mAb anti-Human PTMA, 4A7, Detector | MO-T40087I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9A4 | MO-T40088A | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E6 | MO-T40088B | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 1A10 | MO-T40088C | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5C2 | MO-T40088D | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 10H9 | MO-T40088E | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2A3 | MO-T40088F | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E5 | MO-T40088G | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5H12 | MO-T40088H | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9C7 | MO-T40088I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9D5 | MO-T40088J | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 3E7 | MO-T40088K | 0.1 mg |
| Human PSA ELISA Kit | EL10005 | 96 wells |
| Human IL-8 ELISA Kit | EL10008 | 96 wells |
| Human MCAF / MCP-1 ELISA Kit | EL10009 | 96 wells |
| Human EGF ELISA Kit | EL10010 | 96 wells |
| Human LH ELISA Kit | EL10011 | 96 wells |
| Human TSH ELISA Kit | EL10012 | 96 wells |
| Neonatal TSH ELISA Kit | EL10012N | 96 wells |
| Ultra-Sensitive Human TSH ELISA Kit | EL10012U | 96 wells |
| Human FSH ELISA Kit | EL10013 | 96 wells |
| Human Prolactin ELISA Kit | EL10014 | 96 wells |
| Human SAA ELISA Kit | EL10015 | 96 wells |
| Human SAA ELISA Kit (2nd Generation) | EL10015L | 96 wells |
| Human MCP-3 ELISA Kit | EL10016 | 96 wells |
| Human TNF-α ELISA Kit | EL10019 | 96 wells |
| Human GM-CSF ELISA Kit | EL10020 | 96 wells |
| Human IL-16 ELISA Kit | EL10021 | 96 wells |
| High Sensitivity Human CRP ELISA Kit | EL10022hs | 96 wells |
| Human IL-6 ELISA Kit | EL10023 | 96 wells |
| Human IFN-γ ELISA Kit | EL10024 | 96 wells |
| Human IL-2 ELISA Kit | EL10025 | 96 wells |
| Human IL-4 ELISA Kit | EL10026 | 96 wells |
| Human IL-10 ELISA Kit | EL10027 | 96 wells |
| Human IL-1β ELISA Kit | EL10028 | 96 wells |
| Human TGF-β1 ELISA Kit | EL10029 | 96 wells |
| Human Growth Hormone (hGH) ELISA Kit/Hormone Elisa | EL10030 | 96 wells |
| High Sensitivity Human Growth Hormone (H-hGH) ELISA Kit | EL10030H | 96 wells |
| Human Chorionic Gonadotropin (hCG) ELISA Kit | EL10031 | 96 wells |
| Human IL-12 (P70) ELISA Kit | EL10032 | 96 wells |
| Human IL-2 sRα ELISA Kit | EL10033 | 96 wells |
| Human IL-6 sR ELISA Kit | EL10034 | 96 wells |
| Human IL-5 ELISA Kit | EL10035 | 96 wells |
| HAMA ELISA Kit | EL10036 | 96 wells |
| Human IL-13 Rα2 ELISA Kit | EL10039 | 96 wells |
| Human IL-1α ELISA Kit | EL10040 | 96 wells |
| Human IL-7 ELISA Kit | EL10041 | 96 wells |
| Human IL-11 ELISA Kit | EL10042 | 96 wells |
| Human IL-15 ELISA Kit | EL10044 | 96 wells |
| Human M-CSF ELISA Kit | EL10046 | 96 wells |
| Human TNF-β ELISA Kit | EL10047 | 96 wells |
| Human bFGF ELISA Kit | EL10048 | 96 wells |
| Human Alphafetoprotein (AFP) ELISA Kit | EL10049 | 96 wells |
| Human B2MG ELISA Kit | EL10051 | 96 wells |
| Human Carcinoembryonic Antigen (CEA) ELISA Kit | EL10052 | 96 wells |
| Human IL-17A ELISA Kit | EL10053 | 96 wells |
| Human IL-13 ELISA Kit | EL10054 | 96 wells |
| Human IL-22 ELISA Kit | EL10055 | 96 wells |
| Human IL-9 ELISA Kit | EL10056 | 96 wells |
| Human Amyloid Beta Peptide 42 ELISA Kit | EL10057 | 96 wells |
| Human Programmed Death-Ligand 1 (PD-L1) ELISA Kit | EL10058 | 96 wells |
| Human Programmed Death-1 (PD-1) ELISA Kit | EL10059 | 96 wells |
| Human IL-18 ELISA Kit | EL10060 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Inflammatory) | EM10001 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines) | EM10002 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17) | EM10003 | 96 wells |
| Mouse IL-17A ELISA Kit | MEC1001 | 96 wells |
| Mouse IFN-γ ELISA Kit | MEC1002 | 96 wells |
| Mouse TNF-α ELISA Kit | MEC1003 | 96 wells |
| Mouse GM-CSF ELISA Kit | MEC1004 | 96 wells |
| Mouse MCP-1 ELISA Kit | MEC1005 | 96 wells |
| Mouse IL-2 ELISA Kit | MEC1006 | 96 wells |
| Mouse IL-5 ELISA Kit | MEC1007 | 96 wells |
| Mouse IL-6 ELISA Kit | MEC1008 | 96 wells |
| Mouse IL-4 ELISA Kit | MEC1009 | 96 wells |
| Mouse IL-1β ELISA Kit | MEC1010 | 96 wells |
| Mouse IL-1α ELISA Kit | MEC1011 | 96 wells |
| Mouse TGF-β1 ELISA Kit | MEC1012 | 96 wells |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled) | MO-C40003T | 0.2 mL |
| mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled) | MO-C40003TB | 0.1 mL |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled) | MO-C40017T | 0.2 mL |
| mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled) | MO-C40017TB | 0.1 mL |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, S101, Tracer (HRP Labeled) | MO-C40021T | 0.2 mL |
| mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled) | MO-C40021TB | 0.1 mL |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mL | MO-C40028T | 0.2 mL |
| mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mL | MO-C40028TB | 0.1 mL |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-146, Tracer (HRP Labeled) | MO-C40044T | 0.2 mL |
| mAb anti-Human EGF, S-146, Tracer (Biotin Labeled) | MO-C40044TB | 0.1 mL |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 113, Tracer (HRP Labeled) | MO-C40088T | 0.2 mL |
| mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled) | MO-C40088TB | 0.1 mL |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 323, Tracer (HRP Labeled) | MO-C40089T | 0.2 mL |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled) | MO-C40090T | 0.2 mL |
| mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled) | MO-C40090TB | 0.1 mL |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled) | MO-C40095TB | 0.1 mL |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mL | MO-I40002T2 | 0.2 mL |
| mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled) | MO-L40043TB | 0.1 mL |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled) | MO-L40044TB | 0.1 mL |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mL | MO-M40012T | 0.2 mL |
| mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mL | MO-M40012TB | 0.1 mL |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mL | MO-M40021T | 0.2 mL |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40046T | 0.2 mL |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mL | MO-M40047T | 0.2 mL |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40048T | 0.2 mL |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mL | MO-M40049T | 0.2 mL |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled) | MO-M40050T | 0.2 mL |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin) | MO-M40093TB | 0.1 mL |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin) | MO-M40095TB | 0.1 mL |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mL | MO-T40007T | 0.2 mL |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mL | MO-T40051T | 0.2 mL |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mL | MO-T40052T | 0.2 mL |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mL | MO-T40081T | 0.2 mL |
| Human Chorionic Gonadotrophin (hCG), 10 mg | AP30002 | 10 mg |
| Human Immunoglobulin G (IgG), 10 mg | IG30001 | 10 mg |
| Mouse Immunoglobulin G (IgG), 10 mg | IG41002 | 10 mg |
| Mouse Immunoglobulin G2b (IgG2b), 10 mg | IG41004 | 10 mg |
| Rat Immunoglobulin G (IgG) | IG42003 | 10 mg |
| Human Umbilical Cord Serum, 10 mL | S30010 | 10 mL |
| ELISA Coating (EC) Stabilizer, 500 mL | S7001 | 500 mL |
| Human IL-8 Matched Antibody Pair for ELISpot | SL10008A | 5 × 96 wells |
| Human IL-8 Development Set for ELISpot | SL10008B | 5 × 96 wells |
| Human IL-8 ELISpot Kit | SL10008E | 6 X 96 wells |
| Human MCAF (MCP-1) Matched Antibody Pair for ELISpot | SL10009A | 5 × 96 wells |
| Human MCAF (MCP-1) Development Set for ELISpot | SL10009B | 5 × 96 wells |
| Human MCAF (MCP-1) ELISpot Kit | SL10009E | 6 X 96 wells |
| Human GM-CSF Matched Antibody Pair for ELISpot | SL10020A | 5 × 96 wells |
| Human GM-CSF Development Set for ELISpot | SL10020B | 5 × 96 wells |
| Human GM-CSF ELISpot Kit | SL10020E | 6 X 96 wells |
| Human IFN-γ Matched Antibody Pair for ELISpot | SL10024A | 5 × 96 wells |
| Human IFN-γ Development Set for ELISpot | SL10024B | 5 × 96 wells |
| Human IFN-γ ELISpot Kit | SL10024E | 6 X 96 wells |
| Human IL-12 (P70) ELISpot Kit | SL10032E | 6 X 96 wells |
| TMB Solution (500 mL Part A & 500 mL Part B) | SU6006 | 1.0 L |
| pAb Rabbit anti-HCV Virus, 1.0 mg | AI20006P | 1.0 mg |
| pAb Rabbit anti-HIV-1 p24, 1.0 mg | AI20008P | 1.0 mg |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| pAb Rabbit anti-Mouse IgG , 1.0 mg | AI50005 | 1.0 mg |
| pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mL | AI50005P | 1.0 mL |
| pAb Rabbit anti-hGH, | AI50006P | 1.0 mg |
| pAb Chicken anti-human IL-8 (IgY fraction) | AI60001 | 1.0 mg |
| pAb Rabbit anti-Human FPRL-1 2nd Extracellular Loop | AI70001A | 0.1 mg |
| pAb Rabbit anti-Human FPRL-1 C-terminal | AI70001B | 0.1 mg |
| pAb Rabbit anti-Human PML [Ring Finger Domain] | AI70002A | 0.1 mg |
| pAb Rabbit anti-Human PML [B-box 1 domain] | AI70002B | 0.1 mg |
| pAb Rabbit anti-Bcl-2 | AI70003A | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-2 (Thr56) | AI70003B | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-xL (Thr115) | AI70003D | 0.1 mg |
| pAb Rabbit anti-Phospho c-kit (Tyr719) | AI70004A | 0.1 mg |
| pAb Rabbit anti-Phospho IKK-γ (Ser31) | AI70005A | 0.1 mg |
| pAb Rabbit anti-NF-κB-p65 (RelA) | AI70006A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276) | AI70007A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468) | AI70008A | 0.1 mg |
| pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337) | AI70009A | 0.1 mg |
| pAb Rabbit anti-Human Serum Albumin (HSA) | AI80001 | 0.1 mg |
| pAb Rabbit anti-Human Fibrinogen, 0.1 mg | AI80002 | 0.1 mg |
| pAb Rabbit anti-Human Transferrin | AI80003 | 0.1 mg |
| pAb Rabbit anti-Human IgA, 0.5 mg | AI80004 | 0.5 mg |
| pAb Rabbit anti-human IgM, 0.5 mg | AI80005 | 0.5 mg |
| pAb Rabbit anti-Human TREK-1 (K2p2.1) | AI80006A | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip1 | AI80007 | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip4 | AI80008 | 0.1 mg |
| pAb Rabbit anti-Mouse Kv4.3 | AI80010A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV1 | AI80011A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV3 | AI80012A | 0.1 mg |
| pAb Rabbit anti-Human JAK2 | AI80013A | 0.1 mg |
| pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mg | AI80014 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 42 | AI90001 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 43 | AI90002 | 0.1 mg |
艾美捷科技代理Aalto Bio Reagents品牌。
Aalto Bio Reagents 是一家专注于为诊断、疫苗和生物制药行业提供高质量生物试剂和原料的公司，提供病毒、细菌、激素、人源蛋白、肿瘤标志物、传染病的抗原和抗体。Aalto Bio Reagents 的产品广泛应用于传染病诊断、疫苗开发、生物制药和科学研究等领域。主要业务包括：
（1）诊断试剂原料：Aalto Bio Reagents 提供用于体外诊断（IVD）的生物试剂，包括抗原、抗体、血清和质控品。这些试剂支持传染病（如 HIV、肝炎、流感）、自身免疫疾病和癌症的诊断。
（2）疫苗开发原料：提供用于疫苗开发的生物原料，如病毒抗原、重组蛋白和佐剂。
（3）生物制药原料：Aalto Bio Reagents 提供用于生物制药生产的生物原料，如细胞培养添加剂、纯化试剂和分析标准品。这些原料支持单克隆抗体、重组蛋白和其他生物药物的生产。
（4）GMP 生产：Aalto Bio Reagents拥有符合 GMP（药品生产质量管理规范）标准的生产设施，能够为诊断、疫苗和生物制药行业提供高质量的生物原料。
<<<< " data-original="http://bioassay.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Aalto Bio Reagents品牌"> 艾美捷科技代理Aalto Bio Reagents品牌
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18771149750
传真：13212737804
邮箱：sales@amyjet.com
0.2172
